Phil Micans on How Peptide Bioregulators Help You Age Better, Regenerate Organs, and Improve Your Executive Health
Imagine regenerating your organs, resetting your DNA, and making aging optional. I know, it probably sounds too good to be true.
Our guest for this episode, Phil Micans is here to deliver some top-secret health information that will blow your mind. We will take a deep dive into the world of peptide bioregulators: a Soviet Military secret that is nothing short of revolutionary with incredible safety profiles.
In this wide-ranging conversation, Phil Micans, Pharmacologist, Co-Founder, and Vice President of Profound Health (save 15% off your order with the code EXECHEALTH-15) and Anti-Aging Systems will blow your mind with some of the information shared.
Here are five big points from the conversation, which you can watch below or read the synopsis and transcript further below the page.
Watch the Full Episode Below
Peptide Bioregulators: Powerful Molecular Gene Switches
Peptide bioregulators are short chains of amino acids, discovered in the Soviet Union in the 1980s. These powerful molecular gene switches can either activate or silence specific genes, maintaining homeostasis in our bodies.
They are safe, having been used millions of times over the past 40 years, with no reported serious side effects. These powerful tools are now revolutionizing treatments for health and longevity.
You’ve never heard of them because they would affect the bottom lines of Big Pharma and other mainstream Western medicine industries.
Phil Micans
For over 30 years, Phil Micans has been dedicated and completely immersed in the world of anti-aging and regenerative medicine. Phil spends his time helping to spread the latest international lifespan information to the public by being the Editor of the Aging Matters(TM) magazine and assisting with many other publications and conferences.
He also established the IAS Group in 1991, an organization dedicated to finding hard-to-obtain supplements and health products.
Regulating Your Thyroid, Lungs, Eyes, and Much More
One fascinating application of peptide bioregulators that Phil shared is their role in regulating thyroid health. If you have genes responsible for activating your thyroid to produce more thyroid hormones, bioregulators can activate those genes, leading to increased production of hormones over time.
Conversely, if your thyroid gland is overproducing hormones, bioregulators can silence the genes, bringing your thyroid into a state of balance. This adaptogenic effect makes them safe and effective for managing both hypothyroidism and hyperthyroidism.
Another few examples shared were regarding our lungs and eyes.
Phil shared how bioregulators are revolutionizing treatments for lung and eye health. He recounts his direct experience with a lung peptide that helped a patient avoid a lung transplant.
In addition, eye drops and oral retina peptides can be used to “potentially” reduce cataracts and alleviate dry eyes. This demonstrates the broad range of applications for bioregulators in health and wellness.
Turning Back the Biological Clock
Bioregulators play a significant role in anti-aging and overall longevity, helping us not just live longer, but live better.
The Horvath clock is a tool used to determine an individual's biological age by measuring internal cellular aging. This clock is a valuable tool that helps to monitor and track health and aging, offering insights into an individual's mortality risk based on their biological age compared to their chronological age.
These peptide bioregulators can positively influence the rate at which we age on a cellular level.
For example, Dr. Bill Lawrence's study of 120 patients found decreases in their Horvath age after using bioregulators. Thus showing that these peptides can help us turn back the biological clock.
Aesthetics and Illness Prevention
The potential of bioregulators extends beyond health and longevity. These peptides can target weak points in our body to prevent illness or boost aesthetic appeal.
For example, the use of bioregulators in strawberries has increased fruit production by 20-30%, and similar applications can be explored in humans for aesthetic and wellness benefits. This revelation opens up new possibilities for leveraging the power of bioregulators in food to promote health and prevent disease.
The Future of Stem Cells and Bioregulators
Bioregulators may have the potential to direct stem cells to do what the patient wants them to do, making them a promising tool for future treatments. With their ability to switch genes on or off, bioregulators can guide stem cells to target weak points, prevent illness, or enhance aesthetics.
Conclusion + Thoughts
In conclusion with this conversation with Phil Micans, the realm of peptide bioregulators is fascinating and promising, offering new ways to think about our long-term wellness and longevity.
As we continue to explore and understand these powerful molecular gene switches, we open the door to potential treatments and preventive measures for various health conditions and diseases.
Whether you're a seasoned health enthusiast or simply curious about the world of bioregulators, the insights shared by Phil Micans provide invaluable knowledge that can revolutionize our approach to health, aesthetics, and longevity.
Personally, I couldn’t be more excited about the future of health. For the longest of times, at the minimum, a multivitamin has been recommended.
But what if now, we recommend various bioregulators in a strategic manner? After all, these peptide bioregulators can be thought of as highly specific compounds for specific organs and systems. As another added bonus, we know these compounds can help reduce biological age while regenerating the specific organ and system.
For example, for men, what if we use the testes bioregulator along with the prostate and the blood vessel peptide to completely rejuvenate and help a system we know decreases with time?
We know enlarged prostate’s are problematic for men leading to frequent nocturnal urinations at night and much more potentially problematic scenarios. Leveraging these bioregulators could help shrink (or at least keep at an appropriate level) the prostate. Thus helping to mitigate an issue that affects so many men.
I look forward to leveraging many of these bioregulators along with including them in work with our clients.
Lastly, for peptide bioregulators that are sourced, legitimate, and synthesized properly, Profound Health is the go-to source. As a kind gesture from Phil and the entire team, you can save 15% off your order with the code EXECHEALTH-15.
Head to Profound Health for all the bioregulators mentioned during this conversation and many other amazing longevity and health resources.
Connect with Phil Micans
Website — https://www.antiaging-systems.com/
Store Website — https://profound-health.com/ (save 15% off your order with the code EXECHEALTH-15)
Aging Matters (Magazine) Website — https://aging-matters.com/
Transcript
Phil Micans
(0:00) If one was taking a hormone every day, like the thyroid, for example, you are, by consequence, putting that hormone into your blood, right? (0:11) If you don't do some kind of monitoring and keep yourself in check, in balance, you run the risk of what they call downregulation. (0:23) In other words, you put so much of that hormone into your blood that your own gland says, phew, we don't need to make this anymore.
(0:30) Just stop, okay? (0:32) That doesn't happen with bioregulators because you're operating, you're not putting the hormone into your blood. (0:39) You're instructing your genes to instruct your gland to produce those hormones.
Julian Hayes II
(0:48) Welcome, everyone, to another episode of Executive Health and Life, almost at the old name, Executive Health and Life. (0:55) I'm your host, Julian Hayes II, back at it again, and with one of my favorite words, a fascinating guest. (1:00) And I am not exaggerating this time because today we are talking about peptide bioregulators.
(1:05) You might be like, what in the world is that? (1:07) I know you have heard me mention peptides, but maybe not the bioregulators. (1:12) And this is something that's a secret tool.
(1:14) It's like being let in at a secret club now where you have to have a knock maybe three or four times and didn't say the special word. (1:22) But this tool has been used in the anti-aging longevity world for years now. (1:27) And it's just now scratching the mainstream world, but barely.
(1:31) But nevertheless, my guest is someone who has been involved in the anti-aging community for well over 25 years now, I believe. (1:38) He advises, moderates, and for numerous organizations, including the British Longevity Society, the Monte Carlo Anti-Aging Congress, the Shambhali Conference on Aging and Cancer, and the London Anti-Aging Conference. (1:50) I'm speaking with none other than Phil Micans, who is a pharmacologist, a co-founder, and vice president of Profound Health and Anti-Aging Systems and much, much more. (1:59) Phil, first of all, thank you for getting on the show. (2:02) Secondly, you can do a lot of things.
Phil Micans
(2:06) Well, thanks, Julian. (2:07) It's an absolute pleasure to be here and a big shout out to all your viewers. (2:12) And I hope we can interest them in some of the things we're gonna chat about today.
Julian Hayes II
(2:16) Well, absolutely. (2:18) We are all interested in performing better and doing it for a longer time. (2:22) And so just that simple notion right there would have people's ears pinned up, especially with some of the information that I know you're about to discuss here.
(2:30) So before we start, I always like to get a bit of an origin story because normally with people that are into this health field, especially this kind of space, there's usually a pain point when we're a little, maybe, or in adulthood that steers us on this course. (2:45) So what about yourself?
Phil Micans
(2:46) Yeah, well, I think at least one, I've got two pain points, as you call them. (2:51) I think one of them is a fairly common one, certainly with the people I've spoken to, and the other one's slightly different. (2:58) So the one thing that got me interested from an early age, at least from, say, a teenager, was I always felt that I was aging faster than my mates, than my friends that were close to me for various things.
(3:14) And that got me riled in a way. (3:17) I thought, well, why do I seem to be aging more quickly than my friends? (3:21) That got me interested in the whole topic, I guess, of aging.
(3:26) And the other one was a not uncommon story, was basically having to visit, I was perhaps in my early 20s then, a geriatric ward. (3:38) And in fact, my uncle was in it due to an injury. (3:42) Now, something we ought to point out, the word geriatric, if you ask a geriatric physician, what does the word mean?
(3:49) It actually only means one thing. (3:51) It means being age 65 or older, doesn't mean anything else. (3:55) But in the public perception, of course, it means somebody who's a bit decrepit, a bit past it, whatever expression you wanna use.
(4:04) So my poor uncle, who had all his marbles and was otherwise in good health, despite being in his 80, I think he was at the time, was stuck in this ward, as it were. (4:16) And I used to go along there and chat with him, play cards with him and chess or whatever it was to spend the time with him. (4:22) And I noticed all the other guys who were in the ward, and most of them were by the term we most of us understand geriatric.
(4:32) Some of them had regressed to their early childhood or whatever, and some of them were more or less unconscious, but being given dozens and dozens of drugs through the day. (4:44) And I just came to this very sad conclusion that I don't wanna end up here. (4:50) How on earth?
(4:51) And I have a little saying. (4:53) I say that I think there's two things we ought to do to school kids before they leave school. (4:57) One is get a day trip to a prison.
(5:01) As an eye opener, I say, you don't wanna end up in here, do you? (5:05) Have a think about what you do in your life. (5:07) This is what prison's like, right?
(5:09) And the other one is take them along to a geriatric ward because maybe, hopefully there'll be people amongst them that might say, I'm gonna cure this. (5:19) We're gonna get rid of this problem. (5:21) Or at least they might think about their health long-term because most people don't think about their health long-term.
(5:28) If you did, why would you smoke? (5:30) Why would you drink excess alcohol? (5:32) Why would you eat McDonald's every day?
(5:34) You wouldn't, but people aren't thinking ahead 10 or 20 years or more. (5:40) Most people probably not even thinking ahead one year. (5:43) And that's a tragic consequence because the art of living is to live long.
(5:48) And I love Blondie, the musician. (5:53) And of course, one of her songs was, die young, stay pretty. (5:57) Well, that may be nice to say when you're young, but as you get older, that's not really an option.
(6:04) So how do we live longer? (6:06) But fundamentally, how do we live well?
Julian Hayes II
(6:10) Yes, and now that you brought up those points, I actually hit those two objectives in terms of visiting in prison, did that in high school, and then visited a clinic a long time. (6:20) And then my father was on dialysis. (6:22) And then when I was going to medical school, I did a lot of volunteering.
(6:29) And one of those was in the burn unit. (6:31) Now it's not geriatric, but it is like you get to see some really bad things and some cool people. (6:40) And did some other areas as well.
(6:42) And it does give you perspective in the long term. (6:46) And I started probably in my health journey, probably 19, 20 years old. (6:53) And I thought about, one of the things was, okay, what happens when I'm 35?
(6:58) I just recently turned 37. (7:00) And the goal was when I'm 37, can I still perform like a 25 year old in a lot of my things? (7:08) And that's what I always had in mind, even in my early 20s, to keep that idea in my mind.
(7:13) Because like you said, with health, and this is the thing with weight gain, right? (7:18) You may gain a couple pounds in a year, two pounds, but that's not really enough to move the needle. (7:23) Then the next year, maybe it's a couple more, and then a couple more.
(7:26) But a lot of things with health are slow, slow moving, and you don't notice it in that time. (7:31) And then you just wake up in one sudden moment, or some event happens, and that's when you get a wake up call.
Phil Micans
(7:36) That's true. (7:37) I think eyesight declines like that. (7:39) Take, for example, a cataract.
(7:41) I think most people who develop cataract over time, and that could even be years, at first, they don't notice it, and then a little bit, and then a little, and then the day comes when, I don't know, they have to do their driving exam again, or whatever, and suddenly it's, I really can't read that, you know? (7:57) Or of course, one eye will be a lot worse than the other, as it were, and there'll be some compensation have been going on. (8:02) So you're absolutely right.
(8:04) Over short periods, yeah, the frightening thing in terms of aging is to go back to your filing cabinet, or whatever you have at home, and dig out your old passports. (8:15) Because, you know, the passports generally, you have to renew them every 10 years, generally, and then go back, well, I'm in my 60s now, so I could go back and look at a few of them, and think, God, I really did look like that then, didn't I?
Julian Hayes II
(8:26) Yeah. (8:27) Yeah. (8:28) You know, with eyesight, we're gonna come back to that.
(8:31) It's gonna be one of the regulators I wanna talk about, because I love the eyes. (8:34) That's, you know, if I stayed in school, that's what, I wanted to be an ophthalmologist. (8:38) I love, I love the eyes.
(8:40) Love the physiology of the eyes. (8:41) Yeah. (8:42) And, but the eyesight thing is, that's probably one of my pet peeves, is that people just assume that, oh, because I'm getting older chronologically, that I just need to have poor eyesight.
(8:53) I just don't like that notion. (8:54) But, I'm not gonna go in a soapbox. (8:57) Let's start this whole conversation here.
(9:00) Let's do a, let's learn what are peptide bioregulators, and then also, I guess, what differentiates them from the peptides themselves?
Phil Micans
(9:10) Okay, fine, absolutely. (9:11) Well, of course, there are literally thousands and thousands of peptides. (9:15) What are peptides?
(9:17) They are basically chains of amino acids. (9:20) So, amino acids are, if you will, the fundamental building blocks of life. (9:25) But as soon as two amino acids can join, it becomes known as a dipeptide.
(9:30) Some people believe that's what happened in the primeval swamps, going back millions of years before life existed, that in those bubbling mud pools, two amino acids can join. (9:43) And at that moment was inflammation. (9:46) And we'll get into that.
(9:47) So, of course, the more amino acids you can link, and you can link to big, big numbers, we even start changing the name. (9:55) So, to come back, bioregulators are defined as short chains of amino acids. (10:01) This is two, three, or four amino acids can join.
(10:05) However, as I will explain shortly, not all two, three, four amino acid chains are bioregulators. (10:12) There is a different meaning to the word as well. (10:14) But as you go on to put more and more amino acids onto becoming other types of peptides, you can even start changing the names.
(10:23) You might start calling them proteins. (10:26) And you might even start calling them hormones. (10:28) So, to give one example, if we think about human growth hormone, okay?
(10:34) I think a lot of people are aware of what that is. (10:37) That is actually an amino acid chain of 191 amino acids. (10:41) That's a very, very long chain.
(10:43) And what does it mean when you get some of these from a practical point of view, of a use point of view? (10:49) What does it mean when you have these very long chains of amino acids? (10:51) Well, it means you cannot take them orally.
(10:54) They're not digestible orally. (10:56) They have to be injected or perhaps used as a nasal spray or something like that. (11:01) But one of the advantages of these bioregulators is because they're very short, they can be used orally.
(11:09) They are absorbed into blood, okay? (11:11) There's some other factors here as well. (11:14) So, this discovery, the original discovery of short-chain peptides was made in Russia, made by a very famous man, I think, called Pavlov, who was the, I think all of us know about Pavlov's dogs, you know, how you ring a bell and they got served their lunch and he rang the bell and they started salivating to expect their lunch.
(11:38) So, he came from the St. Petersburg Institute of Biogerontology. (11:43) He was the original discoverer of the short chains of peptides. (11:47) And moving forward, I mean, he did that in, what, the 30s, the 40s, something around that time.
(11:54) Moving, fasting forward to sort of the 80s, 1980s, it was another member of that same institute, a man by the name of Professor Vladimir Khavinson, who went on to discover that these short chains of amino acids are gene switches. (12:12) So, let's bear in mind that they're in foods, they're in different food groups. (12:16) So, for me, when I first discovered these in 2009 or thereabouts, 2010, for me, it was like a light bulb moment because the realization that there is another agent in food.
(12:33) We all know that, you know, vitamins are in food and minerals are in food and fats are in food and fibers in food, but now we know that different foods carry different peptides, bioregulators, and that they act as specific gene switches. (12:48) So, for me, it explains the epigenetics of food. (12:52) But it goes on to be something incredibly fundamental.
(12:57) So, like I say, there are a gazillion peptides out there and we change the names depending on the length of those peptides, but these bioregulators are particularly short ones. (13:09) How many bioregulators are there right now? (13:12) Well, officially available on the market, there are 21.
(13:17) However, they have discovered, I think, nearly 50. (13:22) Because, although I'm sure a lot of folks listening will say, well, I've never heard of these, et cetera, this was work that was started in the 1980s in the Soviet Union and was actually, for the first 20-odd years, a Soviet military secret, okay? (13:42) These supplements, if you will, and they are injections as well, as well as oral supplements, they were used then by their elite troops, their cosmonauts, and, yes, their Olympic teams.
(13:58) This information is now in the public domain. (14:01) It's been in the public domain for about 15 years. (14:05) One of the problems has been that, over that time, guess what, it was all in Russian.
(14:11) So unless you were fluent Russian, you didn't know. (14:14) But now, I wouldn't say all of it, but I would say most of it is in English. (14:19) So, and it's been published, and it's kind of open-source material now.
(14:25) I've helped write at least two books on this subject, one scientific book, which we've called, in fact, it's sitting here in front of me, so I may as well put it up, Peptides in the Epigenetic Control of Aging. (14:37) This is a scientific book, though. (14:39) This goes into detail about what they are and how they work.
(14:43) And another one, which unfortunately is not in front of me right now, but it's on Amazon, and that's called The Peptide Bioregulator Revolution. (14:52) And that's a public book as an introduction to the public. (14:56) So with that in mind, there's still a lot more to be discovered.
(15:01) You know, but what they mainly are, well, I won't go through all 21 and bore everybody, but you've got a lot of glands. (15:08) So you've got like thymus, and thyroid, and adrenal, and pancreas, and pineal, and things like that. (15:15) And there are some tissues, you know, and there are some organs.
(15:19) So there would be, say, stomach, and lungs, and heart. (15:23) So they do cover a wide area. (15:27) They do cover a wide area.
Julian Hayes II
(15:29) So when you're taking these, like how do they exactly work on the body? (15:33) So, because when I hear bioregulator, I think of something like homeostasis, that is gonna bring it back to like equilibrium. (15:40) Is that kind of the right frame?
Phil Micans
(15:42) Yeah, that's a very good expression. (15:44) Another one that's often used, because there are foods that are known to do this, adaptogens. (15:49) So there are plants that are known to be adaptogens.
(15:52) My question now, although I haven't been involved in this research, is are they adaptogens because they contain these peptides, right? (16:01) Could be. (16:02) Because I could mention very briefly to you that there's very recent studies, and I do mean very recent studies, done by the University of Tel Aviv in Israel, where they've used some of these bioregulators in plants, and specifically strawberries.
(16:21) And what they've been able to show is that when these strawberries receive these peptides, they produce 20 to 30% more fruit than the strawberries that don't. (16:30) So although we haven't got into it yet, there have been studies, of course, in vitro, in other words, in a laboratory, in glass, in animals, in humans, and in plants, and they have shown to work. (16:44) So it's something really fundamental, a really basic switch.
(16:49) And what they do, and as I say, because of the nature of what they are, they do work orally, okay? (16:56) They are, and one of the reasons they work orally is apart from them being very short-changed amino acids so they don't get broken down too badly, is they're nano-sized, right? (17:07) They're very, very small.
(17:08) They're nano-sized, and they act directly, and the Russians have got the most amazing slides you'll ever see. (17:14) In fact, sometimes you have to put 3D glasses on to actually see them interact. (17:18) It's really quite a nice experience, where they'll show a specific gene, and they'll show the peptides arriving, and it's linking at certain points, and it's almost like a key going into a lock.
(17:30) And you see, and this is where the rabbit hole, this is where we open the rabbit hole now, okay? (17:36) They either activate or they silence that specific gene. (17:40) Now, even Professor Khavinson has not at least told me when I asked him that they know exactly why. (17:47) How do they know to silence or to activate, okay? (17:50) And this, if you think, let's take, make life easy, let's take the thyroid, okay? (17:57) So if you have genes that are responsible for activating your thyroid to produce more thyroid hormones, then naturally, if you activate that gene, as a consequence, it takes a little time, doesn't, you know, it's not like taking a drug, a hormone.
(18:13) It's not an instant effect, but nonetheless, over a short period of time, your thyroid gland will produce more thyroid hormones, endogenously, naturally, okay? (18:24) You're not forcing it. (18:26) However, if you are making, and of course, there is a large part of the adult population who are hypothyroid to some degree.
(18:35) They're not making enough. (18:36) The late, great Dr. Broda Barnes estimated, in the 80s, I think it was, that over 50% of the adult population was hypothyroid. (18:47) Most of them don't know, right?
(18:49) We just get on with their lives. (18:50) Now, I met his pupil, a lovely man by the name of Dr. Rick Wilkinson, who's still practicing in Washington State today, and I asked him the same question, and I said, you know, your mentor was Broda Barnes. (19:04) You know, 30 years ago, he said 50% of the adult population was hypothyroid.
(19:08) What do you reckon? (19:09) Is it better or worse? (19:09) He said worse.
(19:10) He said it's over 60%. (19:12) Oh, geez. (19:13) Yeah, so that's bad news, right?
(19:15) So, and I'm only mentioning thyroid because when one fixes one's thyroid, a lot of good things happen, right? (19:23) One of those things that a lot of, and there's so many things attributable to it, you think it's hard to believe it's one whole, you know, your sleep, your metabolism, your temperature, all sorts of stuff, right? (19:35) So, but here's the crazy thing, right?
(19:37) If you were hyperthyroid, which is more rare, of course, in other words, your thyroid gland is producing too many thyroid hormones, and you're a completely different person, right? (19:47) You've got too much, dare I say it, you've got too much energy. (19:52) They often have, they're very bright, wide-eyed, bushy-tailed, you know, deer-in-the-headlight look.
(19:59) Some people have said the Mona Lisa was probably hypothyroid because of the way she looks. (20:05) And they have so much energy, you know, you think, wow, these people are amazing to be around. (20:10) But it could be hypothyroidism.
(20:14) Here's the crazy thing, being bioregulators, in those cases, it will silence the genes. (20:20) And what they end up doing is they end up bringing the thyroid into, like an adaptogen, you know, into this band of, how should we call it, normality, okay? (20:34) Now, our bodybuilding friends are not very pleased to hear that when I say to them, if you take the testes peptide as a man, then we'll get into that, because obviously women don't have testes, and therefore, oh, is that controversial?
Julian Hayes II
(20:49) No.
Phil Micans
(20:50) No. (20:53) I'm just looking at this as a scientific perspective, not a political one. (20:59) And on that level, it doesn't gonna do anything for the ladies.
(21:03) And the same thing, there's an ovary peptide, doesn't do anything for the men. (21:07) There's a prostate peptide, doesn't do anything for the women. (21:10) That's the only three.
(21:12) Everything else, we're sharing, okay? (21:14) Well, obviously, in some instances, we don't. (21:16) But with the male bodybuilders, I say, listen, if you're already using other methods to raise your testosterone levels, this thing is not gonna activate your genes, because it knows.
(21:28) So it's that you cannot get supralogical levels of hormones with these peptides, but that brings us back to safety, because the Russians, and when I say Russians, folks, I mean the Russian-speaking countries, right? (21:43) So these things are available in the Ukraine, in Russia, in Kazakhstan, in Armenia, in Georgia, and other countries of Russian-speaking peoples. (21:54) And they have been for many, many, many years.
(21:57) Khavinson reckons they've been dosed to millions of people, probably 100 million times or more, in terms of dosages. (22:04) Never has a serious side effect ever been reported.
Julian Hayes II
(22:10) Whoa. (22:10) Okay. (22:11) So just to stop there real quick.
(22:13) So that's a lot of people. (22:14) So this is not even something that's like, I have to go get a prescription for, or this is like something that's commonplace. (22:21) It is.
Phil Micans
(22:22) Now, if it was injectable, you'd have to go get a prescription, because by definition, an injection is a drug. (22:28) If you put vitamin C in a vial, and you're gonna inject it, it becomes a drug, okay? (22:34) Nasal sprays, same thing, right?
(22:37) But the oral versions are food supplements. (22:40) So they're over the counter. (22:43) That's amazing.
(22:45) Wow. (22:47) So there's a lot to this. (22:48) And I think the most amazing side to this story is that folks say, oh yes, it sounds tremendous technology, but we need time, don't we, to make sure.
(22:58) I say, we've had time. (22:59) We've got 40 years of published data that's been released by the Russians, by the Ukrainians, by the Kazakhstanis, et cetera, et cetera, et cetera. (23:09) It's all there.
(23:10) Now, sometimes, sometimes I hear us Western people or some Western person, because they grew up with the Cold War, say, oh, but you can't trust them, can you? (23:24) Right? (23:24) For whatever reason.
(23:26) And I say, I'd rather you look at the science than the politics. (23:30) But then I turn around and say, well, would you trust an American doctor? (23:36) And normally the answer is, of course, yes.
(23:38) And I say, why? (23:39) And then I'd like to point you to the work of Dr. Bill Lawrence, who lives in Atlanta. (23:45) And he's been studying these now for four or five years.
(23:48) He has 120 people in his clinical trials. (23:53) He's been mimicking the Russian protocols and all of his patients have benefited in various ways. (24:01) And we didn't mention it, but I'm the editor of a magazine called Aging Matters.
(24:06) And we have published his work in that magazine. (24:09) It's designed for the public. (24:13) And of course, fascinatingly, Bill has been doing things with his patients that perhaps the Russians didn't do in the 90s.
(24:21) Because it was difficult to get. (24:23) There are certain tests now that were very, very hard to do 20 and 30 plus years ago. (24:28) For example, telomere testing.
(24:30) Or the Horvath clock, the DNA methylation. (24:34) And he's showing that all his patients improve their telomere length. (24:38) In other words, they get longer and improve their DNA methylation as well.
(24:44) So, which is probably the single best biological age measurement we have. (24:50) Okay, we can get into that if you want to. (24:54) But so, there's a doctor, 120 patients.
(24:59) They've all been in at least three years of clinical trial. (25:03) And the results are there to be seen. (25:05) So, it is beginning to get out there.
(25:09) And I know lots and lots of other doctors from all parts of the world who are using it on their patients who report. (25:16) But of course, they haven't done it in a clinical sense. (25:18) They've done it in their own practices, et cetera.
(25:20) But Bill, he's doing it on a formal process. (25:27) So, the information is getting out. (25:28) So, like you said at the top of this, Julian, this stuff has been out there a long time.
(25:34) But as is so often the case, I'm afraid, in health and medicine, it can take decades before the general public get to actually learn of it.
Julian Hayes II
(25:43) Yeah, I mean, for example, fasting is a craze right now. (25:48) My goodness, we were doing these alternate day fasts and five day fast, three day fast. (25:53) I was doing this back in university.
(25:55) So, I was probably, that's back 2005, sixes? (25:58) Yeah. (25:59) So, I mean, it's over a decade that just that kind of information.
Phil Micans
(26:03) Yeah, most of the world's major religions, the way I look at them is whichever book you like to read, there's information in there that they didn't understand at the time. (26:16) Like, I don't know, don't sleep around because God will send you a venereal disease. (26:23) Well, they didn't understand the process of it, but don't eat, have periods where you don't eat, go off into the desert and fast for a few days or whatever.
(26:33) Okay, they didn't understand why, but actually it was all basic information that they were trying to pass on to future generations. (26:43) So, you're absolutely right. (26:45) Nothing new under the sun, right?
(26:48) It's just perhaps that we get more detail in understanding it, but there are some basic things and you're absolutely right. (26:55) Fasting is a good thing. (26:57) And now we're discovering, of course, it doesn't mean that you have to go days without food.
(27:01) It might be 16 hours. (27:04) So, you know.
Julian Hayes II
(27:06) Yeah, and so I'm gonna come back to the Horvath clock and some of that stuff because I mean, to start using that, because I've done age testing myself and telomere testing as well. (27:18) And so, and then it's also a way for, like I said, when a lot of us are coaching, advising other people, not clinically, as they say, but lifestyle, right?
Phil Micans
(27:28) Lifestyle. (27:29) Healthy fitness.
Julian Hayes II
(27:31) Health and fitness, right? (27:32) That's how we call it. (27:33) And these kinds of things are valuable because then you can say that, okay, these things that maybe people might look at you weird for or just might be a little foreign to you, we can back it up.
(27:43) And we have something to measure it against. (27:45) So I'm gonna come back to that. (27:46) But beforehand, I saw when I was doing a little research, I saw that there was a particular study in Siberia about the effects of mortality and morbidity on these, with these regulators.
(27:56) I thought that was pretty cool.
Phil Micans
(27:57) Yeah, no, absolutely. (27:59) I think one of the incredible things under the Soviet Union, because of course then it was a communist state and Khavinson actually got a call in the 80s directly from the Kremlin. (28:09) And he was a colonel in the medical corps.
(28:12) So at that time, so they said to him, you know, we've got troops in nuclear submarines, in nuclear silos, and there were certain weapons they wanted to get their troops guarded against, lasers on the battlefield that would make them go blind. (28:29) They said, find things that will help our troops. (28:31) And that's how it started, okay?
(28:34) And they went down, you know, different avenues as it were, but it was designed originally to assist their military. (28:41) But they soon started using them when they discovered it. (28:44) And one of the fundamentals is it induces protein synthesis.
(28:49) So you get repair done a lot faster. (28:52) And when you think about, say, for example, cosmonauts or astronauts, if you want to use another terminology, going up to space is a hazardous environment, you know? (29:03) And even if the astronauts, cosmonauts exercise in space, they still deteriorate.
(29:08) And when they, if they stay up there for a long time, like a year or something, and then they come back to the planet, they really struggle to get back on track. (29:18) So that's when the peptides really help them recover very quickly. (29:22) One story that shocks a lot of people is when the London Olympics took place, which I can't remember the date, but it wasn't that long ago, there was a Russian female gymnastic team that won gold medal, okay?
(29:38) So there was about, I don't know, six or eight of these young ladies, you know, sort of 18 to 21 or something like that. (29:46) And they won gold in the Olympics. (29:49) So they're at the top of their game, right?
(29:50) And of course, if you look at them, you go, wow, they're fit. (29:53) You know, of course they would be, wouldn't they? (29:55) But this is where we get into the concept of hormesis, which hormesis is mild stress.
(30:03) And this is a theory by Suresh Rattan, Professor Suresh Rattan out of Denmark. (30:09) And basically mild stress is good for us. (30:13) And that's what exercise is, isn't it?
(30:15) It's a mild stress, a little bit of damage to the muscles, and then it repairs and it grows and so on and so forth. (30:20) But like everything in life, the curve is either bell-shaped or U-inverted, and you wanna be in the middle. (30:27) You know, you don't wanna drink too little water, but you don't wanna drink too much water, right?
(30:31) And it's kind of true of everything. (30:33) You wanna be in the middle. (30:34) So doing over-exercise, which obviously training for the Olympics and what have you is push, push, push, push, push.
(30:43) And what they were shocked at was when these girls returned to Russia after winning gold, they did their telomere tests, and they were twice their age. (30:52) They were 40-year-olds in terms of telomere testing. (30:55) And they put them on the peptides and they recovered very quickly, okay?
(31:00) So it's part of the inducing protein synthesis. (31:04) And also, this is where aerobics in older people is a dual-edged sword because all that rapid uptake of oxygen, so if you're a long-distance runner or, I don't know, in the Ironman competition or something extreme, and you're older, your body doesn't have the natural defenses it had when it was in its 20s, and it can be very damaging. (31:28) And if you want to know more about that side of things, I highly recommend a book written by a free radical expert.
(31:36) His name is Dr. Richard Lippman. (31:38) Lovely man, Richard. (31:40) And he wrote a book called Stay 40, and he describes free radicals, our natural defenses to them, the best supplements to negate them.
(31:51) But he also shows the damaging effect of over-aerobic exercise in the over-40s, okay? (31:57) Okay, I got a few more years. (32:01) Well, that's a generality.
Julian Hayes II
(32:03) You know there are some- Yeah, yeah, I know, I know. (32:04) I'm just joking. (32:05) I'm just joking with you.
(32:06) We got all these toys and everything, but yeah, I know what you mean.
Phil Micans
(32:10) So, you know, this is where I kind of come in is, as we age, what can we do as we age to protect ourselves? (32:19) Because, you know, there's two ways forward with health and fitness, isn't there? (32:23) The two ultimate way.
(32:24) Either we prevent the bloody problem in the first place, right, because we don't really want disease, do we? (32:30) We prevent the problem. (32:32) That's fantastic.
(32:34) But should we start on the path towards that problem, or God forbid, get the problem, then we want to regenerate. (32:42) I try to avoid the word rejuvenate. (32:44) So that's the most fabulous word.
(32:46) But regenerative medicine, right? (32:49) Why not? (32:50) Make us biologically younger wherever possible, obviously.
(32:56) So, yeah, the bioregulators, in my over 30 years of being in the business, and I've gone through various, I hesitate to use the word fads, but there's always been demands for certain things, okay? (33:10) So in my early career, and I'm not saying those demands have gone away, but in the early career, everyone wanted to talk about smart drugs, nootropics, that sort of thing. (33:20) Later on, bioidentical hormones, and they still are, and they're still very powerful tools, don't get me wrong.
(33:27) But today, it's definitely peptides, without doubt. (33:32) And let me just say this about the bio, I can't say of all peptides, can't say of all peptides, but let me say this about these bioregulators that we're focusing on. (33:42) If one was taking a hormone every day, like the thyroid, for example, you are, by consequence, putting that hormone into your blood, right?
(33:52) If you don't do some kind of monitoring, and keep yourself in check, in balance, you run the risk of what they call down regulation. (34:04) In other words, you put so much of that hormone into your blood, that your own gland says, we don't need to make this anymore, just stop, okay? (34:13) That doesn't happen with bioregulators, because you're operating, you're not putting the hormone into your blood.
(34:20) You're instructing your genes to instruct your gland to produce those hormones. (34:27) And as we've already alluded to, there is this activate and silencing mechanism. (34:33) So you're not going to go over, it's going to keep you within this bandwidth.
(34:37) I think that's what explains their safety factor. (34:42) I'm not recommending, of course, that people don't monitor themselves. (34:47) That's not what I say, but I can say that there is a far greater bandwidth of safety than by using hormones.
Julian Hayes II
(34:56) Yeah, and if anything, when you're monitoring yourself, I think it's just good, especially with stuff like this, is you get to actually see things that are improving. (35:04) Yes. (35:04) And I think that's the thing that is most amazing, is that you can just pick a body part, say like, I don't know, maybe your lungs or something.
(35:13) Your lungs are messed up when you go to the doctor or something, or they're not at their capacity as they should be. (35:18) Maybe you use some of these regulators for a while, and you go back, and you can compare and contrast the difference, most likely.
Phil Micans
(35:26) I think there's a good argument, Julian, for whatever you do. (35:30) Could be exercise, could be taking vitamins, could be having a sauna every day. (35:37) You know, it could be taking more specialist supplements like these peptides, hormones, whatever.
(35:42) You know, do a before and after. (35:44) You know, I mean, everything, I think, comes down to cost and convenience, right?
Julian Hayes II
(35:50) Yeah.
Phil Micans
(35:50) If the program you're gonna go on is very costly, it's gonna make you think twice about it, isn't it? (35:56) If you're gonna go on a program that's very inconvenient for your lifestyle, it's gonna make you think twice about it. (36:02) So if you have a program that you say, I can afford that, it fits into my lifestyle, it's not really inconvenient, you're much more likely to go with it and adapt to it.
(36:13) So I think everything comes into that category. (36:16) But even if you throw a load of vitamins and minerals down yourself every day, ask yourself, are you at least wasting your money? (36:25) And did you do any before and afters?
(36:28) Did you discover that you were low in B12, just as an example, and required it, you know? (36:33) And then you started taking the B12. (36:35) Did you, even in six months, it doesn't have to be every week or anything.
(36:39) And of course, there are physical things that you can test yourself for. (36:45) I'm always, not that I'm a big expert on testing, I'll say that right now, but I'm always fascinated about what doctors did before there were blood tests, right? (36:54) What was the old fashioned way of doing it?
(36:56) And the classic, sorry, I keep raising the thyroid, but it's a nice easy one, is what's your morning temperature? (37:04) When you get out of bed first thing in the morning, take your temperature, because that's the thyroid pointing to my neck because it's there. (37:11) That's the thyroid because it's regulating our body temperature.
(37:15) It's very, very important to keep it within a really very narrow bandwidth. (37:21) What is it? (37:21) Write it down.
(37:22) You know, it's so easy to take a, you know, put it on your forehead, stick it in your ear, beep, you've got the temperature. (37:27) Write that down. (37:28) And over about two weeks, go and have a look and see what number comes up the most.
(37:33) And you'll be shocked how close they are. (37:35) I'm sorry, I'm gonna talk in Celsius. (37:37) Somebody will have to get the calculator out to work out Fahrenheit.
(37:40) But your normal healthy thyroid is between 36.3 and 36.7 Celsius. (37:48) So if you're seeing those numbers, okay.
Julian Hayes II
(37:51) 97, that's 36.3 is 97 degrees Fahrenheit. (37:55) Okay, cool.
Phil Micans
(37:57) So if you're over that and you're within, what, 0.4 C, then you're fine. (38:04) If you're regularly over 36, 6.7, then you're hyperthyroid. (38:07) You've got too much going on.
(38:09) But if you're regularly below 36.3, and I've even had patients in the 34s, which is horrendously low, right? (38:18) Then you could do with some thyroid support. (38:22) Okay, I'm not saying that peptides is the only answer.
(38:25) There are many ways of going, several ways of going at this. (38:29) So, and that is a way, and again, I've just come back to the fact that if you get your metabolism back and you get your, your sleep cycles will improve and you'll probably drop some weight. (38:41) And, you know, there's been a whole bunch of things going on there.
(38:45) You'll feel more energized. (38:47) You might even lift any depression that might be going on. (38:50) You know, there's a lot of things happen.
(38:52) The adrenal glands is another one. (38:53) And I'm pointing this out because there are certain peptides I find that when the patients use them, they get, I get the quickest responses. (39:02) I get the, within a month or so, within one to three months, this is a, I would say is a typical time period, okay?
(39:08) Don't give up on them within three months, okay? (39:11) It will depend on all sorts of other reasons. (39:15) But if you're using the protocol correctly, and we can get into that, then one to three months should be a timescale where you should see some kind of benefit improvement.
(39:26) And if you're keeping some kind of daily, weekly record, whether it's through blood or physical or temperature in the case of the thyroid, you will see those changes, or you certainly should see those changes. (39:39) So, which is great, you know, then you know you're taking the right product. (39:44) Because otherwise, it's like having a shotgun.
(39:47) You take a whole bunch of vitamins and everything. (39:50) What you're doing really is a shotgun approach. (39:52) Maybe I'll hit the target.
(39:54) But if you've got a rifle, you know, bang, you know you're on target. (39:59) So that's the way I look at it.
Julian Hayes II
(40:02) Much more precision as well. (40:03) So I just wrote that down, that we will come back to the protocol. (40:06) But the thing that we wanted to come back to even before that was also the Horvath clock in terms of measuring aging.
(40:13) Because I think that's, like you said, one of the best, if not the best tool right now in that regard.
Phil Micans
(40:19) Yeah, it's actually, why did I say it's probably the best single biological age measure? (40:27) I don't believe that if you're going to evaluate your own biological age, it is actually very hard to do. (40:35) Because, and I have actually been involved with making a piece of software many years ago that took in up to 150 different markers.
(40:43) And we realized very early on that getting that one number that everyone wants, my biological age is, and then of course, they're delighted when they're under their chronological age and they're upset when they're over their chronological age, as always. (40:57) But it was very, very hard because there were all, you know, one, you might do a, just to throw some things out there, right? (41:04) You might do a DHEA test and the report might say, bad news, you're 10 years older on your DHEA.
(41:13) But you might do an eyesight test and find you're five years younger and so on and so on and so forth. (41:17) So it's very hard to get this one uniform number. (41:22) But you might be able to look at certain, some biological age markers are critical.
(41:28) Now, for example, the graying of hair, although my daughter says it's white now, mine, is, you know, a biological age marker. (41:37) But here's the good news, it's not gonna kill me, right? (41:40) So on the other hand, you know, I've got certain heart markers or whatever that are okay or good, which is great because if I had some bad cardiovascular markers, well, yes, I could be dead tomorrow.
(41:53) You know, so we have to weight certain mark. (41:58) Hand grip strength, for example, is quite a well-known, decent biological age marker. (42:04) But is it vital?
(42:05) Is it life-threatening? (42:07) You know, so, you know, there are certain problems with biological age measurement. (42:12) But let's come back, sorry, to the Horvath.
(42:14) So Stephen Horvath, who's a doctor from, I believe, UCLA, he determined how DNA methylates. (42:24) And he came up with this biological age clock, which has become named after him, the Horvath clock. (42:31) And it's one of those that is incredibly narrow because there are certain biological age measurements where you might do it and they'll say, oh, right, you're 37, Julian.
(42:44) Well, well done because this marker, you're 20. (42:47) And you go, great, yeah. (42:50) Oh, hang on, but this marker, you're 50.
(42:53) And you go, oh, no, you know. (42:55) But they can be, what I'm saying is there can be very wide discrepancies, okay? (42:59) But the Horvath test seems to be particularly narrow, okay?
(43:05) It's pretty rare if it's plus or minus four years, okay? (43:11) And that makes it one of the hardest to change. (43:15) And I have heard rumor, although I can't tell you which ones, because I don't know, but I've heard rumor there are some police forces who are now, if they go to a scene of a crime and they find some blood or whatever, saliva, whatever, and they think it's from the perpetrator, they take the sample.
(43:33) What can they find out? (43:35) They can find out the blood group. (43:37) They can find out the sex.
(43:39) And of course, if they've got the DNA on file, then they know who the person is. (43:44) If they haven't got the DNA on file, what else can they know from this? (43:49) All they can do is keep the sample in the hope that if they get the person, they match the two samples, right?
(43:54) But otherwise, what can they know? (43:55) Well, I've heard that some of them are now using the Horvath test, because they can now say plus or minus four or five years what the age of the person is. (44:06) So now they know they're looking for a 30-year-old or a 40-year-old or whatever, right?
(44:10) So that's a tool the police haven't had before. (44:14) So with that in mind, and there is a formula, which I'm sorry I haven't got it in front of me, but we have published this in our Aging Matters magazine, that shows the risk of increased mortality if your Horvath age is older than your chronological age. (44:35) And unfortunately, it's not linear.
(44:36) So for example, if it was, if we said five years increases plus, increases your mortality by 100%, four years isn't 75, 50, 25, it doesn't go like that. (44:52) Unfortunately, it kind of goes up big. (44:55) So in other words, one year, it might be like a 10% increase in mortality older, two years might be a 15%, you know what I mean?
(45:04) Three years is like 35, it goes up like that. (45:07) And it's something similar in reverse. (45:10) Okay, not quite as good actually, which is rather, you know, depressing.
(45:16) In other words, if I'm five years younger from my chronological age on a Horvath test, I might decrease my chance of mortality by 50%. (45:26) That's a big number, still worth it, right? (45:29) But if I'm five years older, I increase it by 150%, right?
(45:36) So it's skewed. (45:37) But having said that, the name of the game, of course, in anti-aging, is to try and be as biologically young as you can. (45:46) So that's, in essence, the Horvath test, it is perhaps the most accurate, and it is the hardest to change.
(45:53) And actually, although it's a few years old now, Dr. Horvath did make a statement saying he didn't know any way, apart from saying stop smoking and stop drinking and, you know, all that stuff, all the basics. (46:07) He didn't know any other way. (46:09) Certainly, you might slow it down, but not to improve it.
(46:13) Well, Bill Lawrence, come back to Dr. Bill Lawrence in Atlanta, with these 120 patients, that's exactly what he's seeing using these bioregulators. (46:23) He is decreasing the patient's Horvath age. (46:28) Oh, wow.
(46:29) They are improving their DNA methylation. (46:34) And I think if I remember correctly, and please don't hold me to it, the best result they've seen is a reversal of five years. (46:44) Now, that's a big number for the Horvath clock.
(46:47) On the telomeres, the best number, I spoke to him a couple of months ago, so it may have been different by now, but I think the biggest number they saw was a decrease in biological age on telomeres of nine years. (47:04) You can get bigger numbers on telomeres. (47:07) I accept that, okay?
(47:09) But that's both, in other words, longer telomeres for that particular patient. (47:13) So it's all good news. (47:14) And by the way, these are not young people.
(47:17) There are no 20-year-olds. (47:19) I don't even think there are any 30-year-olds in his study. (47:21) I think if I remember rightly, everyone's between sort of 40 and 80.
Julian Hayes II
(47:25) Oh.
Phil Micans
(47:25) Yeah. (47:27) And by the way, most of them are medical doctors, really weirdly. (47:30) Don't ask me how that happened, but here they are.
Julian Hayes II
(47:32) I'm gonna have to look this up. (47:34) This sounds very interesting to look at this. (47:38) Okay, so now let's go to, I think we set a good foundation.
(47:43) Let's dive into some of these different regulators, protocols, and that kind of thing. (47:47) And then I'll go from there. (47:50) I guess the first good place to start is, someone's probably hearing about this.
(47:55) They're going to the website. (47:56) They see there's like 21 that are on the market right now. (48:00) So how in the world would I know where to start, what to use?
(48:04) And I think this probably goes into probably your recommended protocol.
Phil Micans
(48:08) Yeah. (48:11) It's added complications. (48:13) Sorry about this.
(48:14) There are natural versions, which at the moment are bovine extracted, and there are synthetics. (48:20) There are quite as many synthetics as there are naturals. (48:23) When I said 21, I was referring to the naturals, okay?
(48:26) Okay. (48:27) So just put that out there. (48:29) The other thing I don't want to really get into to bore everybody is the name change, the brand names and all that.
(48:35) Oh my God. (48:36) It's like learning another language. (48:38) One of the hardest things with our jobs is to learn the chemical names, the brand names, another name for it, you know?
(48:45) And the Russians really confused it because they named it one name if it was natural, another name if it was synthetic, another name if it was injected, and oh, so you could have the same thing with four different names. (48:57) So we'll just stick with the gland.
Julian Hayes II
(48:59) Yes. (48:59) You know, I was going to say something like that, right? (49:01) That was actually going to be one of my questions that I was like, make sure to ask him because I was looking at, for example, the blood vessel one and we'll talk about that one, I'm sure.
(49:11) And I saw the synthesized was vesigin, and then I saw the natural was vent four. (49:16) And then all these other different ones. (49:18) I was like, this is like, this is like, I'm going to have to like learn this in a class again.
Phil Micans
(49:23) Yeah, I know. (49:24) I know. (49:25) We've tried very hard on our websites.
(49:27) We will list brand names, you know, when you go to the store, but when you read the information, we just refer as a synthetic or a natural. (49:37) Most of the studies, by the way, are on the naturals. (49:40) Okay?
(49:40) I can tell you a little bit of a difference we've seen in the clinical side of things between naturals and synthetics, if you want. (49:48) By the way, I apologize because you did ask me a question earlier and I didn't finish it for you. (49:52) You said to me there was a trial in Siberia.
(49:55) Okay. (49:55) I should have mentioned that because it is very important actually. (49:59) And also that will lead us directly to what I think are the core three peptides, okay?
(50:05) Okay. (50:06) From studies. (50:07) And that was a study in, as correctly stated, in Siberia, in nearly 12,000 people.
(50:15) I mean, you don't remember, under the Soviet Union, you know, Communist Party, if they want it, they do it and they do everything in a big way, right? (50:23) So they took 12,000 people who worked in Gazprom, that's oil and gas workers, people working in Siberia. (50:30) So this is not office workers in New York, right?
(50:33) This is a pretty tough environment straight away. (50:36) Okay. (50:37) And I think about 3,000 of them, if memory serves me right, were put onto a placebo, which were basically multibits, okay?
(50:46) So they didn't know whether they were getting peptides and they didn't know whether they were getting multibits. (50:51) So they followed these people up. (50:53) They followed the core of these people up over six years.
(50:56) They followed another percentage of them up over another four or five years. (51:02) And then 1,000 people were taken on beyond 12 years. (51:08) Now, bear in mind when these people started, they were sort of age 35 to 60.
(51:14) So some of these people at the end of 12 years, you know, 77, 78, you know, retired obviously and all the rest of it. (51:22) And yet they followed them up. (51:23) Now, it was true that they changed the protocols over time, but there were three core peptides.
(51:33) I'm not saying they were the only peptides used, but there were three principal ones and they were the pineal, the thymus, and the blood vessel, okay? (51:44) And to that point, and we'll come on to how you choose and what you do, but those are the three I take on a regular basis. (51:55) And I'll get into why I personally do that.
(51:59) But what did they discover? (52:00) Let's get to the brass tacks, as they say. (52:03) What did they discover?
(52:04) They discovered that the people who, the workers who took the peptides compared to the workers who took the vitamins, they had one third of the morbidity. (52:18) So in other words, those taking peptides suffered one third of the problems of the people who didn't. (52:26) A reduction of 66% in problems, medical problems, okay?
(52:34) Well, that's a big number straight away, okay? (52:38) And shockingly, they went on to find in the long-term studies, especially like after the 12-year point where people are getting into their 70s. (52:49) And I want people to understand that living in that part of Russia, people do not have an average as lengthy lives as we do.
(52:58) If everyone's thinking, well, we all live to about 80 average, they don't in that part of the world, right? (53:05) Or they didn't, okay? (53:06) So what did they find with the folks taking the peptides in mortality, in deaths?
(53:13) Yes, very similar number. (53:16) They had two thirds less deaths, okay? (53:20) So something really fundamental is going on.
(53:24) Khavinson, Professor Khavinson, the main man, he refers to this as a biological reserve. (53:30) He actually says that every cell in the human body has a biological reserve of about 30% and that these peptides are actually activating this biological reserve, okay? (53:44) Now, is it a coincidence?
(53:47) I just put this out there as an idea for people to, I don't know, have a beer tonight and think about. (53:54) Is it a coincidence that the average age of death in the West is about 80 and yet the maximum verifiable lifespan is about 120? (54:06) I mean, Jeanne Calment was 122, nearly 123, but 120 is really the upper limit. (54:13) A difference of about, oh, 30%. (54:18) So this number keeps coming up. (54:22) This around 30% number keeps coming up in, do you remember, did I, oh, I can't remember if we said it when we had the pre-chat or, but they did a study on plants in Tel Aviv.
(54:33) Pre-chat, pre-chat. (54:34) Sorry. (54:35) So let me just tell folks, very recent research, I mean, literally months old, comes out of Tel Aviv.
(54:43) They use some of these peptides in strawberry plants and the strawberries that had the peptides produced about, oh, 30% more fruit than the ones who didn't. (54:55) So there's something very fundamental going on here because the studies have been in a laboratory, what we call in vitro, in glass. (55:03) They've been in animals, they've been in humans, and now they're in plants and they operate in all of them because they're the peptides in foods that we all consume one way or another and we know their gene switches.
(55:20) So it's very fundamental, very fundamental.
Julian Hayes II
(55:24) So pineal, thymus, and the blood vessel.
Phil Micans
(55:28) Yes, I would, now, how do you choose it? (55:30) Let's go back and ask that question, that $64 trillion question. (55:35) Used to be a million, but that's not very much money anymore, is it?
(55:39) Unfortunately, no. (55:42) $64 trillion question. (55:45) So what do any of us choose to do in anything?
(55:49) You're sitting at home and you're watching this because obviously you're interested in health and wellness and great, good on you. (55:56) That's a great subject to be interested in. (56:00) How do you choose what to do?
(56:02) What kind of, why did you choose that kind of exercise over that kind of exercise? (56:06) Why do you eat that kind of food over that kind of food? (56:09) Why do you take a sauna every week?
(56:11) We could ask all those questions. (56:13) So when it comes to using supplements, whether they be hormones or drugs or food supplements or whatever, why did you make that choice? (56:24) Well, I think fundamentally there are probably two reasons, okay?
(56:29) And the first one is perhaps the most important one. (56:35) What is your weak point? (56:37) Now, if you have a problem, if you know you're diabetic, if you know, I don't know, you've got arthritis or you're gonna go for it, right?
(56:46) You're gonna say, oh, every time I move, my knee hurts, my hip. (56:50) You're gonna focus on that. (56:51) It's gonna get your attention.
(56:53) Or my eyesight's failing or whatever it is. (56:56) That's your weak point. (56:58) So it's only natural that you start there.
(57:02) And rightly so, and rightly so. (57:04) Now, if you're a nice, healthy person and you're doing pretty okay, how do you know? (57:11) Well, there's two ways, isn't there, really?
(57:14) One, you actually go out and have some tests done. (57:18) And then you discover your telomeres aren't that good or your hormones are a bit low or whatever it is. (57:24) And then you've got something to focus on.
(57:27) If you don't even know that, I would suggest look at your family history. (57:33) What did dad die of? (57:35) What did grandma die of?
(57:37) Whatever, right? (57:38) I mean, unfortunately, there are three diseases that carry around with most families. (57:44) And it could be heart disease, senile dementia or cardiovascular, okay?
(57:50) And I suppose diabetes as well. (57:52) So you might want, if you wanna look to the future and see what your grandparents died of or your parents died of, that may be a focus for you. (58:01) Because now you know you might have it.
(58:04) Of course, you can go and get the tests. (58:05) You can have the genetic tests and find out. (58:07) That would be wonderful if you do that.
(58:10) So I think those are the ways. (58:12) And then there is also the aesthetic side, isn't there? (58:15) People don't like their skin or they don't like their hair or whatever.
(58:19) Then that's another choice. (58:20) That's another choice. (58:21) So all these decisions we based on.
(58:24) So if you're deciding which bioregulators you want to use, what are your weak points? (58:30) If you know you have weak adrenal glands, as an example, that's an easy decision. (58:36) Take your adrenal peptide, right?
(58:38) So that, or what your parents suffered from. (58:41) So now you're perhaps using it as a preventative, okay? (58:45) And we can talk about dosages and how they change between treatment and prevention.
(58:50) So I think that would be the prime places to start. (58:55) If you're really not sure after all that, then my recommendation are those three peptides that I mentioned, because they were shown in very large clinical trials to have a long-term benefit for people over decades in reducing their morbidity and their mortality. (59:19) So, and I think there's a number of reasons for that.
(59:22) If you will, excuse me, Julian, I'll just quickly talk about those three. (59:28) Absolutely. (59:28) Thank you.
(59:30) The pineal, as a gland, holds a very special place for me in terms of, in my earlier career, I worked a lot with the great Italian doctor, Walter Pierpaoli, and Walter is a melatonin expert. (59:45) Oh, I read that book a long time ago. (59:46) Exactly.
(59:47) He wrote all the early books, you know? (59:49) He's a big, big man in the world of melatonin and the pineal, et cetera. (59:54) And I think we all know if you draw, if you take the center of your forehead and then you do another one over the tops of your ears and you drew two lines, you'd find the center of your brain and there you would find this pea-shaped and sized gland called pineal.
(1:00:11) And as we know, it reacts to light. (1:00:14) So when we get into darkness, i.e. when we go to bed, it starts to produce melatonin. (1:00:22) And melatonin, it does a number of things, but the principal thing about melatonin is it tells the entire endocrine system when to produce its hormones.
(1:00:35) In other words, it's now, melatonin's in the blood, it's nighttime, guys, take it easy, shut down. (1:00:43) In most cases, right? (1:00:45) And then once sun comes up, morning comes, melatonin starts to leave the blood, the pineal gland stops producing it, and a lot of hormones come up.
(1:00:54) So first thing in the morning, you're gonna have that pulsite release of growth hormone, testosterone, whatever. (1:01:01) Most hormones are at their highest first thing in the morning. (1:01:04) It's the get up and go impetus.
(1:01:07) That's not to say they don't produce smaller pulsite waves later on, measurable as in blood I'm talking about. (1:01:15) That's still true. (1:01:16) But Walter once described the pineal gland to me like this, and it has stuck with me ever since, because I thought it was a brilliant concept.
(1:01:25) He said, Phil, he said, think of the pineal gland as the conductor of the endocrine orchestra. (1:01:36) So that's all the other glands in the body, endocrine, okay? (1:01:38) So, and I said, what do you mean?
(1:01:40) He said, well, if you have an orchestra and you don't have a conductor, what does it do? (1:01:45) It makes noise. (1:01:47) But you give it a conductor, it makes music.
(1:01:51) And it's pretty well known that either through melatonin or through the normal operations of pineal, you end up on your circadian rhythms. (1:02:00) In other words, day, night, day, night, day, night. (1:02:03) Because we all know what it's like to suffer two or three nights with no sleep.
(1:02:07) We know how bad we all feel, right? (1:02:09) And that's why, unfortunately, a lot of the people who work on jet aircraft have a lot of problems, because they're in Australian time zone this week, and they're in New York time zone that week, and all the rest of it's a mess, especially for the ladies with their periods, et cetera. (1:02:25) So that's one, and shift workers, of course, who maybe work days and then work nights, whatever.
(1:02:30) So if you get nice, healthy circadian rhythm, you get hormonal cyclicity. (1:02:35) And when you've got hormonal cyclicity, you've got a strong immune system. (1:02:39) So that's fundamental.
(1:02:40) So I think the pineal peptide has a role in all of that. (1:02:45) And I think it does two things fundamentally. (1:02:49) Well, we know it does.
(1:02:51) One, it helps our pineal gland, especially as we get older, because it's about getting older and the decline for various reasons in our body's ability to, in this case, produce hormones. (1:03:03) It helps the pineal gland endogenously, in other words, naturally, produce more melatonin. (1:03:11) But it also, I think, is the principal mover and shaker in extending telomeres.
(1:03:19) So that's why, for me, the pineal peptide is at the top of the tree. (1:03:25) The thymus peptide is, the thymus is in our chest. (1:03:31) It's quite a large gland.
(1:03:33) It is unfortunately the first gland to a trophy with age, in other words, get smaller. (1:03:38) And it happens at puberty. (1:03:39) And some people believe that's the moment of aging.
(1:03:43) From birth to puberty, it's growth and development. (1:03:47) And then nature says, ah, you're able to reproduce. (1:03:52) Time to die.
(1:03:53) And things go in decline. (1:03:55) So a lot of key researchers in the field consider aging to start at puberty. (1:03:59) So in other words, 13, 14 years old.
(1:04:03) But it's shown by the atrophy, the shrinking of the thymus. (1:04:10) The thymus produces 13 hormones. (1:04:14) And they're peptides, 13 thymic peptides, okay?
(1:04:21) There's been lots of studies on different, and there are individual thymus peptides slash hormones that you can use. (1:04:31) But by taking the thymus bioregulator, you're helping your own thymus produce more of all. (1:04:38) So it's a much more natural approach.
(1:04:40) And of course, having a healthy thymus means having much stronger immunity, okay? (1:04:46) That's a fundamental thing about the thymus. (1:04:49) It also, according to German trials, seems to have a major improvement on people suffering with rheumatoid arthritis, okay?
(1:04:59) And finally, as I spoke about three, the blood vessel peptide, which is actually from the aorta. (1:05:07) And Khavinson, I interviewed him a few years ago, and I asked him about synergistic peptides. (1:05:13) In other words, which combinations produce a greater effect for a given problem, okay?
(1:05:20) And in every single combination was the blood vessel peptide. (1:05:26) It was synergistic with all the peptides. (1:05:29) When you think about it, it's extremely simple.
(1:05:32) Because what you're doing, you're doing a number of different things. (1:05:37) There is some evidence of increased nitric oxide production, which is very healthy to help dilate arteries, improve blood flow, et cetera. (1:05:46) But you're also, by improving blood flow, what are you doing to every cell in your body?
(1:05:53) You're delivering nutrition more, better, shall we say. (1:05:59) And at the same time, you're helping remove those toxins from the cells better. (1:06:04) So it's pretty obvious if you improve blood flow throughout the body, that that's a benefit.
(1:06:10) I could go off on a side story here, but I won't unless you tell me to. (1:06:14) About the blood flow? (1:06:16) About this one?
(1:06:16) It's about blood flow and blood thickness, specifically, and arterial stiffness.
Julian Hayes II
(1:06:22) Well, I think that's, yeah. (1:06:24) I think, let's hear that. (1:06:25) Because, I mean, this is actually, this is probably one of the big issues with most people.
(1:06:30) One of the things that's usually likely to trip someone up is a issue with circulation. (1:06:34) And this is actually near and dear to me, because this is one of the things that, with my family history, that if I was going by that model, I would definitely pay attention to that.
Phil Micans
(1:06:47) Gotcha. (1:06:47) Well, you know, I won't go down too many rabbit holes here, but it's funny, I was watching a video just earlier today about a cardiologist doctor basically making the point that I'm not gonna tell the cholesterol story today. (1:07:03) I promise you that.
(1:07:03) But he was basically saying, you know, if cholesterol is the big bad guy for heart attacks and clogging up arteries, et cetera, how come, in the 50s, of course, there was an explosion in heart attacks, how come since the invention of statins, heart disease still remains number one killer? (1:07:22) Doesn't make sense, does it? (1:07:24) But anyway, I'm not gonna tell that story today.
(1:07:25) If you want to have me back by, you know, then we perhaps can go down that rabbit hole. (1:07:31) But here's the one I like best, and it's something that at least every man out there can do, and I hope will be interested in. (1:07:39) So these are facts.
(1:07:41) So a man up to the age of about 50 has twice the risk of a heart attack or stroke as a woman. (1:07:49) Up to the age of about 50, okay? (1:07:52) That's well known.
(1:07:54) A bit odd, a bit unfair for us men, isn't it? (1:07:57) But past the age of 50, women catch us up. (1:08:02) And by 60, they even overtake us in terms of their risk of having a heart attack or a stroke.
(1:08:10) Now, that to any researcher should be ringing bells and saying, well, what on earth is going on there? (1:08:15) And the late great American cardiologist by the name of Kenneth Kensey wrote a book, you can still pick them up for peanuts on Amazon, called The Blood Thinner Cure, where he evaluated at that time all the major markers, okay, for the risk of a heart attack or stroke. (1:08:35) And his conclusion in the book was, there are two markers that are way ahead of all the other markers, the most important to know.
(1:08:44) And they are your blood viscosity, in other words, how thick is your blood, and your arterial stiffness. (1:08:51) And his conclusion was, if you keep relatively thin blood and you keep relatively soft arteries, your risk of a heart attack or stroke is minimal, despite what your cholesterol, C-reactive protein, HbA1c, triglycerides, homocysteine, or anything else is doing, okay? (1:09:08) Now, to come back to the ladies and the gents, what happens to a woman at about the age of 50?
(1:09:17) Well, she goes through menopause. (1:09:19) Now, I wholeheartedly accept that as her estrogen levels go down, and her progesterone, by the way, because everyone forgets about that, but as her estrogen levels go down, typically by about 60%, okay? (1:09:34) So from her youth to her old age, her estrogen might be 60% less.
(1:09:40) By the way, her progesterone levels can go down 100%, right? (1:09:44) And again, that brings us back to the late, great John Lee, who wrote a lot of books about progesterone, and I think they're still extremely valid. (1:09:52) But, so that's, now, we know estrogens, particular kinds of estrogen, have heart-protective qualities.
(1:10:00) So it can well be argued that the lady losing those levels of estrogen is increasing her risk of the heart attack, okay? (1:10:07) Accepted. (1:10:08) What happens to a man past the age of 50, and particularly at 60?
(1:10:14) Do you know a man of 60 can often have more estrogens in him than a 60-year-old woman? (1:10:20) Because men feminize, because the aromatase, the enzyme that's predominantly found in fat cells, and is responsible in a man for converting his testosterone, specifically to estradiol, is on the increase. (1:10:36) And you know that, because the men put on weight, they get the old boob situation going on, they get, you know, you hear an old man on the phone, right?
(1:10:46) You know it's an old man. (1:10:48) The voice is gone. (1:10:50) That's maybe more to do with very low testosterone.
(1:10:53) But what's happening is a man's testosterone level's going down, his estrogen level's going up, older men, and in the women, estrogen levels are going down. (1:11:01) Although there is an argument that their testosterone's going up, because the same enzyme, aromatase in women, is converting their estradiol to testosterone. (1:11:09) That's how women get testosterone, that's how we get estrogen, without us having ovaries and them having testes, right?
(1:11:16) Okay. (1:11:17) So there is an argument to say those hormonal changes are increasing the risk for the ladies for the heart attacks and maybe, maybe, decreasing the risk for men. (1:11:29) But something else is going on that's a lot more fundamental.
(1:11:32) What do the ladies do when they've gone through menopause? (1:11:35) They stop bleeding. (1:11:37) They stop giving blood every month, right?
(1:11:42) The act of giving blood is forcing the bone marrow to produce more blood. (1:11:47) And in the act of that, you could argue that toxins are being released. (1:11:52) A lot of people who are into bloodletting do it to get toxins out, that's possible.
(1:11:58) For iron also, right? (1:11:59) Iron is also, absolutely. (1:12:01) But they're also forcing their blood to get thinner, okay?
(1:12:06) So you think, oh, that's all great theory, Phil. (1:12:09) You know, lovely theory, but it's not backed up by anything, is it? (1:12:12) Well, unfortunately, if you're a naysayer, it is.
(1:12:15) And that is, if you go to the blood bank people and you get the figures for them, and of course they've done millions and millions of people, okay, it turns out that if a man donates one pint of blood every six months, because he's altruistic, right? (1:12:32) And we've got to keep the hospitals with their blood banks. (1:12:35) Of course we do.
(1:12:37) He reduces his risk of a heart attack or stroke by 50%. (1:12:43) Wow, wow. (1:12:45) Why?
(1:12:46) Because he's thinning his blood. (1:12:48) So keeping blood, and that's not the only way. (1:12:52) Enzymes can do it.
(1:12:53) Even drinking lots of water can do it. (1:12:55) But I mean, I'm just making the point that keeping blood relatively thin, obviously not too thin, and keeping arteries relatively soft is extremely protective in terms of the risk of a heart attack or stroke. (1:13:12) And when you think about it, to get a bit sort of serious for a moment, if one was unfortunate enough to get cancer, most cancers, very sad situation, but it's probably taken time to get to that position.
(1:13:30) And in most cases, there is still plenty of time to do something about it. (1:13:37) Cancers rarely kill people that quickly. (1:13:41) You've got months and even years before it might get on top of you, shall we say.
(1:13:48) A heart attack, you might know about it as pains down the left arm in the morning and be in a morgue in the afternoon. (1:13:55) So in some respects, guarding against cardiovascular or strokes, of course, you could argue is at the top of the list because it could kill quick. (1:14:08) So anyway, I don't want to put a depressing thing on this, but in terms of prioritizing what your health requirements are, you might consider that those want to be near the top.
Julian Hayes II
(1:14:20) Well, that's a great explanation of why those three are, because like you said, it's pretty much the conductor to the orchestra, the governor, whatever analogy you want to use. (1:14:33) And then the blood vessel, we need blood flow everywhere in our body.
Phil Micans
(1:14:36) And you know, the very recent studies, again, we've published this in the Aging Matters Magazine because that's what we try and do. (1:14:42) We try and find the latest international stuff and put it in front of people. (1:14:47) American professor by the name of Reiter, spelled with an R, R-E-I-T-E-R, he made a discovery a few years ago now that tumors only grow in the daytime.
(1:14:58) They don't grow at nighttime. (1:15:01) And it's pretty interesting, you know? (1:15:03) And of course, the first thought they had was, well, what's in blood in the day?
(1:15:08) Not in the day, and it's at night, melatonin. (1:15:11) So there are a number of clinics around the world now who are dosing very high dosages of melatonin. (1:15:18) And I'm going to mention one very fine gentleman by the name of Dr. Frank Shallenberger, who's in Nevada. (1:15:24) And he can be found on YouTube talking about this. (1:15:28) And he's giving his patients somewhere between 180 to 240 milligrams of melatonin in the daytime, because normally you take melatonin at nighttime. (1:15:39) Wow.
(1:15:40) And I believe they're doing all right. (1:15:42) I don't know if they've had regression, but I believe they've had no progression. (1:15:47) So that's a step in the right direction, isn't it?
(1:15:50) So, and here's the weird thing, right? (1:15:53) Here's the really weird thing. (1:15:54) When the cancer patients take those extreme dosages, I mean, I would suggest that healthy people wouldn't normally take more than about three milligrams, maybe six milligrams, but I wouldn't go above that.
(1:16:10) So with a cancer patient taking 180 or 240 milligrams, normally, if you were to take a mega dose of melatonin at night, you'd probably feel pretty drowsy in the morning. (1:16:20) You probably wouldn't wake up too quick. (1:16:23) There is a way around it, and that is go and get as much sunlight as you can, okay?
(1:16:26) But that will help get the melatonin out. (1:16:30) But that's a problem, and some people, most common people say, oh, I feel drowsy using melatonin. (1:16:36) So your dose is too high, take the dose down.
(1:16:40) So, but guess what? (1:16:41) These cancer patients don't feel drowsy, even on these mega doses. (1:16:46) And I have actually got personal experience of a cancer patient who was taking very large dosages during the day, and when she was finally tumor-free, for various reasons, I won't go into now, but, and it wasn't chemotherapy, radiation, or surgery.
(1:17:07) So I'll just say that. (1:17:09) She decided to take some high dosages again, super drowsy, couldn't handle it. (1:17:15) But then she was cancer-free, tumor-free at that time.
(1:17:18) So there's something going on there. (1:17:20) Wow.
Julian Hayes II
(1:17:21) Wow. (1:17:23) And maybe we'll do that part too, in terms of why you're probably not gonna hear a lot of this. (1:17:31) You hear a lot of these things, because this is a good tie-in, actually, to the next segment that I'm gonna talk about, is it's like a 10-day supply.
(1:17:40) When I went on the website, it's like a 10-day supply. (1:17:43) And you also mentioned already that these are not things that you just use consecutively for 12 months out of the year. (1:17:49) It's something that you cycle.
(1:17:51) So it's not a lifetime prescription of just taking this thing, which, if you get my drift, you already can see why this is in competition with another certain type of industry already. (1:18:03) So with that said, though, okay, so say I'm getting ready to, I wanna get this general protocol of these three. (1:18:11) They're 10 days supply for each one.
(1:18:14) Yeah. (1:18:15) Do I take each one every day, or am I rotating? (1:18:20) What's the order of mechanism to do that?
(1:18:22) Yeah, no problem, Julian.
Phil Micans
(1:18:23) So first of all, if you had a problem that you wanna address, you would take two capsules a day for at least a month, 30 days. (1:18:34) So now you would take 60 capsules. (1:18:36) Okay.
(1:18:37) If you had a problem. (1:18:39) The Russians refer to that as the intensive dose. (1:18:43) Now, I'm not saying that in their clinics, they don't also use the injections, or we could get into one or two things with that if you want me to.
(1:18:50) But that's where they would start. (1:18:53) But it's pretty rare that the patient stays at two capsules a day every month. (1:19:00) That's pretty damn rare.
(1:19:02) Most folks, the 80-20 rule, right? (1:19:04) Most things in life come down to the 80-20 rule. (1:19:07) So most folks, at least 80% of them, would take two capsules a day for 10 days in the month, and the rest of the month, not at all.
(1:19:19) So that's why 10 days or 20 capsules, whichever way you wanna look at it, because there's 20 capsules in a pack, right? (1:19:27) Is for at least 80% of folks is enough for the whole month. (1:19:31) And then the next month comes around, and you would take another 10 days course.
(1:19:36) And then the next month comes around, you take another 10 days course. (1:19:39) It's part of this relationship between the genes and the glands and the tissues where you do not need to, unlike a hormone, where you do not need to supply it every day, okay? (1:19:52) Now, if one is super fit, or if one is seeing improvements, remember I said, give it one to three months, that regimen can come down to every three months.
(1:20:07) So now we're talking about taking these peptides for 10 days, every 90 days. (1:20:16) Okay, that's good news, because it comes back to my cost and convenience, right? (1:20:21) Then suddenly the cost has gone right down and the convenience factor has improved, right?
(1:20:26) So that's pretty typical for most people. (1:20:30) Now, you can take as many peptides of these bioregulators, I should say, all the time. (1:20:40) So if you wanted to be on six of them, and you wanted to spend 10 days every month taking all six, you can.
(1:20:48) There's no crossover conflict. (1:20:51) There's not an issue there.
Julian Hayes II
(1:20:52) Okay, that's good. (1:20:53) So, okay, yeah, that's very good, and so that's very easy to remember for someone. (1:20:58) So, hypothetically, at the first of the month, I'm going through this trio here, taking it for 10 days, and then that's it.
(1:21:06) And then if I have a problem, I take it again the next month.
Phil Micans
(1:21:09) Exactly.
Julian Hayes II
(1:21:10) At the beginning.
Phil Micans
(1:21:10) Well, there is a certain area of judgment that isn't clear, because individuals being individuals, there are so many factors in their lifestyles, their condition, et cetera, that we're unaware of. (1:21:25) The issue is, how long will those genes stay activated or silenced? (1:21:30) And when do they need to get that message again?
(1:21:32) That's why typically it's recommended between one and three months to take a 10-day course. (1:21:38) Hey, listen, I do know some folks out there who take it every six months, right? (1:21:43) That's their, they're kind of super fit, super healthy.
(1:21:46) They're just kind of taking the precaution or whatever you want to call it. (1:21:52) So, now, my personal regimen, because when I get up in the morning, because one of the problems is a lot of us who are in this field, we probably take quite a bit of stuff.
Julian Hayes II
(1:22:03) Yes.
Phil Micans
(1:22:04) Everything, a bit of extra magnesium, bit of extra zinc, a little bit of this, a little bit of that, whatever it is you're into, right? (1:22:11) Whatever it is. (1:22:12) But, you know, or my amigas, can't forget them, blah, blah, blah, blah.
(1:22:16) And so, you start looking at your watch saying, I don't think I'm ever gonna get out of the house here. (1:22:20) I'm taking this, I'm taking that, and the rest of it. (1:22:23) So, what I do, there are three peptides, as I've told you, that I'm on regularly.
(1:22:27) That's the pineal, the thymus, and the blood vessel. (1:22:30) I get up in the morning, there's the blister, I pop two out, I swallow those, have breakfast, whatever. (1:22:38) It doesn't need to be taken with or without food, but my preference is with food, because if you're having some food, it's easy to remember, oh, where's my capsules?
(1:22:48) It's just an easier thing to do. (1:22:51) And then, so I take one. (1:22:53) So, for 10 days of the month, I'm taking one of the peptides, and then, oh, that blister's empty, in the bin.
(1:22:59) Where's the other one? (1:23:00) Oh, next peptide. (1:23:02) So, 10 days on peptide one, 10 days on peptide two, 10 days on peptide three, and if there is 31 days in the month, oh, I'm not taking anything.
(1:23:11) But it's just a convenient way for me to get up in the morning and be saying, where's my peptide? (1:23:17) That really depends on how organized you are. (1:23:22) But there's no harm, there's no issue in taking all those peptides on 10 days, if that's what you want.
(1:23:31) So, that's really your choice.
Julian Hayes II
(1:23:33) So, it's all about your pill-propping preference. (1:23:36) Exactly. (1:23:37) Okay, so, because that would be, if you do it all at once, in just the first 10 days of the month, that is six a day, right?
(1:23:44) Yes, if you were taking three peptides, that's right. (1:23:46) Yeah, that's six a day. (1:23:48) I mean, to me, that's nothing, that's easy.
(1:23:51) Exactly. (1:23:51) But to a lot of people, a lot of people do not like those. (1:23:53) So, that's, once again, where the bio-individuality comes into this.
(1:23:56) And a lot of this is about your personal preference. (1:23:58) Yeah. (1:23:59) You have to really consider that.
(1:24:00) And I think this is another good benefit of these regulators, is that they're very flexible. (1:24:06) Yeah. (1:24:06) Because a lot of different compounds, you have to take every day.
Phil Micans
(1:24:10) Yeah. (1:24:11) Let me just throw some dollar figures out there for folks. (1:24:14) Now, so they get an idea of what the cost of the technology is, okay?
(1:24:19) Now, we'll talk US dollars, of course, because the whole world knows the value of their currency to the US dollar. (1:24:27) Even if that's changing rapidly. (1:24:31) I'm sorry.
(1:24:33) Keep politics out. (1:24:34) Good joke. (1:24:35) Good joke.
(1:24:37) Sometimes all you can do is laugh. (1:24:39) Sometimes all you can do is laugh. (1:24:41) Exactly.
(1:24:41) Exactly. (1:24:42) I totally agree. (1:24:44) So, if you think about the cost.
(1:24:47) Now, they're not all priced exactly the same. (1:24:50) There are basically three different prices. (1:24:54) The Pineal is the most expensive one. (1:24:56) You're looking at about, depending on how many you buy, because that's the old equation. (1:25:01) If you buy a few boxes, they get a bit cheaper and all the rest of it. (1:25:04) But you're looking at between 60 and $70 for 20 capsules, okay?
(1:25:09) The bone marrow one, which helps with stem cells, by the way, you're looking at about $10 less. (1:25:17) So you're looking at sort of 50, $60. (1:25:19) And then virtually all of the others are between 40 and $50, okay?
(1:25:25) Now, so if you're gonna take one peptide, at worst, it's gonna cost you around $40 a month. (1:25:33) At best, it's gonna cost you $40 every three months. (1:25:37) So, I won't mention any other names, but there are some mega expensive supplements on the market where you'd be putting at least a zero on the back of that.
(1:25:48) So, from that perspective, I think, I know not everyone will agree with me, but I think they're affordable.
Julian Hayes II
(1:25:55) Yes, no, honestly, when I saw that, because even the peptides, some of the peptides can actually get up there, especially if you're doing some very frequent dosages. (1:26:06) So they can get up there. (1:26:08) So when I actually saw this, I was like, wow.
(1:26:11) I was really taken aback. (1:26:13) I was like, this is fantastic. (1:26:15) Another reason why, once again, I see why the other side of things would want these things to be suppressed.
Phil Micans
(1:26:23) Oh, of course. (1:26:24) I'm not denying that we're conscious of, and when they, in the world of health and fitness, it's very hard to make claims. (1:26:33) I mean, basically, as far as the authorities are concerned, food supplements are meant to do absolutely nothing.
Julian Hayes II
(1:26:39) Nothing.
Phil Micans
(1:26:42) We have certain, here in the UK, our agency literally has come out and said anything that makes a biochemical change within the body could be considered to be a drug and therefore under their purview. (1:26:54) Well, that sounds great until you think about it. (1:26:57) So that sunlight, drinking water, eating a steak, going for a jog around the block, everything makes a biochemical change in us, you know?
(1:27:06) That's just, it's a ridiculous statement to make.
Julian Hayes II
(1:27:09) Very much so. (1:27:10) Wow. (1:27:11) That's, I can't.
(1:27:12) So, you mentioned the bone marrow, and so I was just having a conversation this week about stem cells. (1:27:21) And would that peptide be able to help increase stem cells?
Phil Micans
(1:27:26) We are not aware, at the present time, if it increases stem cells, but it appears, from the doctors we've been talking to who have been doing various tests, it increases the activity of the patient's stem cells. (1:27:39) So that is one that's kind of coming up, how should we say, on the rails sort of thing, in that that's a fairly recent discovery that we're watching closely. (1:27:50) But I think we're all aware that certain substances can improve the activity of our own stem cells.
(1:27:57) So I, by the way, just as a side note here, I went to a stem cell conference in the Bahamas about two months ago, and that was very interesting, I found it very interesting, but a very good conference. (1:28:10) But one of the things I was trying to advocate and suggest, because one of the biggest problems that stem cell clinics have, I know there's different choices in stem cells and whatever, but the universal problem that they have is directing those stem cells to do what the patient wants them to do.
Julian Hayes II
(1:28:30) Right.
Phil Micans
(1:28:31) And often, I'm sure you know this, you need a kind of trauma for stem cells to work. (1:28:37) You know, if you cut your hand, then the stem cells will start going there as, ah, you know, trauma, start fixing it. (1:28:44) That's one of the theories behind cancer, because there are cells, cancer is us, right?
(1:28:50) But it's just growing, it won't go into apoptosis, and the tumor gets bigger and bigger. (1:28:55) Cancer stem cells, they see the tumor as a trauma. (1:29:00) And so they're adding and adding and adding to it in that particular, that's a strange case, but that's a different case.
(1:29:07) But with, so I think, and this is only my theory at the moment, I have to say that there could be a role in certain peptides and particularly these bioregulators as specific gene switches to help instruct those stem cells where to go. (1:29:25) So, you know, if you have a certain tissue, certain gland that you want, it could be very helpful to take the peptide with the stem cells and get more out of the $20,000 you just spent on those stem cell injections.
Julian Hayes II
(1:29:38) Yeah, that's my whole thing with stem cells is why I can't really recommend it yet, because it's too many unknown variables. (1:29:44) And the precise nature of usually what someone would be interested in those for is I don't know if it's even close to, it's not even close to 100% yet.
Phil Micans
(1:29:54) And we come back to the cost and convenience. (1:29:56) Right. (1:29:56) So now you have to be a pretty wealthy person, the kind of people that can afford to go down on a submarine in the Atlantic.
(1:30:03) Shouldn't mention that. (1:30:06) To spend, experiment by spending at least $20,000 having some stem cell injections.
Julian Hayes II
(1:30:12) Yeah. (1:30:12) So that's one of the things. (1:30:14) So quickly, I'm going to ask some more about some of the other different peptides, but so hypothetically you have someone who has a problem, a situation, and let's take the, you could say the lungs are the kidneys, right?
(1:30:28) They're not performing as well. (1:30:30) And if you have the synthesized version and then the natural nature version, the bovine, would it make sense initially for like at least that first month to do the synthesized since it's theoretically a stronger dose?
Phil Micans
(1:30:45) Yes, it does. (1:30:47) And that is actually what they do in the Russian clinics. (1:30:49) They actually put the patient on the synthetic version for the first month, and then they transfer them to the natural.
(1:30:57) Now I've had this conversation with the clinicians over there, and because this is a bit weird because a chemist is going to say, I'm looking under the microscope at this synthetic peptide, and it's exactly the same as this one under the microscope. (1:31:12) It's a natural peptide, okay? (1:31:15) So the chemist is like scratching his head saying, why do they have a different methodology?
(1:31:20) It's a bit like asking, why does the synthetic vitamin act differently to the natural vitamin, okay? (1:31:27) And I have two answers to that, but we'll come back to that. (1:31:31) But what the Russians do with people with problems is they put them on at least one month of synthetic and then transfer them to the naturals.
(1:31:39) Why do they do that? (1:31:41) Because what they say is the synthetics will work faster. (1:31:47) However, the naturals will last longer.
(1:31:53) So you at least have the possibility with the naturals to get down to those 10 days a month, or possibly 10 days every three months, just depends on the condition. (1:32:04) Whereas I would say there's a possibility that you may have to take the synthetics more regularly on that basis, okay? (1:32:12) So there is a variance.
(1:32:13) How can there be a variance when the chemicals, when the formula looks the same? (1:32:18) I only two answers to that. (1:32:21) Are this, the devil's in the detail.
(1:32:26) Natural molecules may have a certain matrix about them that is not present in a synthetic molecule. (1:32:35) And that's why I worry about the artificial foods that we're being inundated with. (1:32:41) They're just presuming there's nothing else in there than fat and protein and what have you, right?
(1:32:47) What about magnetism? (1:32:48) What about light? (1:32:49) What about peptides?
(1:32:51) What about things we haven't even discovered yet, okay? (1:32:54) Because there's something that's present in every molecule. (1:32:58) It's called frequencies.
(1:33:00) And different frequencies, as we all know, I think that you may be familiar with the Japanese studies with water, where, I can't forget the guy's name, I apologize. (1:33:12) The French also did a lot with this as well. (1:33:15) Where different emotions into water, they held a different frequency.
(1:33:22) The structure of the water changed. (1:33:25) The molecules rearranged themselves, whether you said to the water, I hate you or I love you. (1:33:31) And it didn't matter what language you were speaking or even they wrote them on bits of paper and stuck them on.
(1:33:37) It was a frequency that we're all, I think, all admitting. (1:33:41) So I think, and it could also explain why homeopathy works. (1:33:46) Because a chemist is gonna say, there is none of that chemical in that water.
(1:33:50) Homeopathy is a joke. (1:33:52) But what if the frequency, as the Japanese have shown, retains in the water of that chemical? (1:33:59) So there's something else going on.
(1:34:01) And to me, my theory is that the natural peptides may have different frequencies. (1:34:10) When I did pharmacology many years ago, there was a moment where we were showing there was certain receptor. (1:34:16) And a hormone, for example, is on route to the receptor.
(1:34:19) But it hasn't actually docked yet. (1:34:23) And yet the receptors reacted. (1:34:26) How could that be explained?
(1:34:28) It can't be explained by a chemist. (1:34:29) But it could be explained if the frequency from that hormone has already arrived. (1:34:37) That to me is, so it's an area of, dare I call it medicine, that is obviously not.
(1:34:44) And of course, there's a whole electromagnetic medicine is all on a different, on those levels, isn't it? (1:34:50) But everything has a frequency. (1:34:52) This table, this computer screen, my glasses, everything's creating frequencies.
(1:34:58) The world, we're spinning on a globe, that's creating, everything's, we're surrounded by them. (1:35:02) Everything's in rotation.
Julian Hayes II
(1:35:07) Yeah, it's overwhelming to think about sometimes. (1:35:10) It's just like how much things are going on. (1:35:12) And I even think about what a lot of compounds that, we have a great understanding, but there's so much that we still don't understand.
(1:35:20) And this is a great example. (1:35:23) Most of the time, for people with a little more serious of an issue, they start with the synthesize. (1:35:28) And then gradually move over to the natural.
(1:35:31) But that's like a- Oh, absolutely.
Phil Micans
(1:35:33) The German doctor I met quite a few years ago now is named Dr. Christian. (1:35:38) And his study showed that drugs perform better during solar eclipses.
Julian Hayes II
(1:35:45) I've never heard that.
Phil Micans
(1:35:48) He published it. (1:35:49) But that's one of the problems you were saying about, how do we get this information out? (1:35:55) My old joke is, I mean, I don't profess to know everything.
(1:35:58) I'd be an idiot if I did. (1:35:59) Same here. (1:36:00) I just written a piece actually, I hope to put in the next magazine called, Can AI Save Us?
(1:36:06) And I'm looking from one perspective, which is to read everything that's ever been published and cross-reference it for us. (1:36:12) Most of the world's information isn't online. (1:36:15) It's like 80% of the world's population is still in the libraries.
(1:36:18) Multiple languages, all the rest of it. (1:36:21) Every year, there are a million medical publications produced in one year. (1:36:25) Just the medical side of it.
(1:36:27) Who can read everything? (1:36:28) Nobody can. (1:36:30) And so every now and again, we discover something and we go, we've got about seven, what I call wow stories.
(1:36:36) And this is one of them. (1:36:38) These peptide bioregulators are one of those stories. (1:36:40) Where when you say, did you know this?
(1:36:42) Did you know? (1:36:42) And it's, you know, they go, wow, it's incredible. (1:36:44) Why don't we know about this?
(1:36:45) Why isn't it commonplace, et cetera? (1:36:47) So my old joke is, if you want to keep something a secret, publish it.
Julian Hayes II
(1:36:52) Publish it. (1:36:54) Yeah. (1:36:54) You know, unfortunately they said, there was a saying growing up, and this is a lot of families said, if you want to keep something a secret, like you said, put it in a book.
(1:37:06) It's another way that people said put it in a book because they're not going to read it.
Phil Micans
(1:37:09) That's right. (1:37:10) Who's going to read it all? (1:37:11) And even then, unfortunately, most of the nature is unfortunate of us humans.
(1:37:15) It needs to be repeat, repeat. (1:37:16) And we've lived in this advertising. (1:37:18) I mean, look at what we've just come through.
(1:37:22) The almost propaganda. (1:37:24) Every 15 minutes we were warned, you know, whether you were switching on the radio, the TV, looked at a poster or whatever, or read a newspaper. (1:37:32) The mess, bang, bang, bang, bang, bang, bang, bang, bang.
(1:37:36) It's a kind of propaganda. (1:37:37) And unfortunately, I think modern humans, we don't get subtlety anymore. (1:37:42) You know, and it's a very sad situation that stories need to be repeat, repeat, repeat, repeat, repeat.
Julian Hayes II
(1:37:50) And you talk about frequency. (1:37:52) Yeah. (1:37:52) There's no greater way to lower frequency than to constantly be bombarded with fear, with death, with struggle, 24 seven.
(1:38:03) That is an easy way to lower your frequency.
Phil Micans
(1:38:07) I don't know psych ops, but I think we've come through something like that. (1:38:11) Yeah. (1:38:11) We get blasé to it.
(1:38:13) We switch off to it or whatever. (1:38:15) And coming back to the Pineal, and of course, a lot of people, it can over calcify. (1:38:19) It's quite well known that the Pineal can do that. (1:38:22) And there are methods, of course, to decalcify. (1:38:25) A lot of people spend, you know, in the Hindu religions, I think this spot here on the forehead is called the Bindu or the Bindai, Bindu, I think. (1:38:32) And it represents the third eye, which is the pineal gland.
(1:38:35) And some people say, this is consciousness. (1:38:38) This is the connection to the ether for universal consciousness. (1:38:42) So, you know, all spiritual religions say, you've got to get your consciousness up and get in tune with the universe.
(1:38:51) And yeah, I'm beginning to think along those lines. (1:38:54) I think there is, I personally believe that the brain is not a computer, but it's a receiver. (1:39:00) So how do you raise your consciousness?
Julian Hayes II
(1:39:05) I could, that could be a whole nother conversation. (1:39:07) And so I'm going to finish off talking. (1:39:10) I want to cover a few more of these peptides.
(1:39:12) And so the heart one was interesting to me in terms of like the exact mechanisms. (1:39:17) What is that like doing in the heart there?
Phil Micans
(1:39:21) Well, again, specific gene switches. (1:39:24) It will help to get arrhythmia or to negate arrhythmia, to get the heart pumping more regularly, more forcefully, strengthening some of the internal muscles and that kind of thing. (1:39:39) So, and again, that one, of course, combined with the blood vessel, which is going to do two fundamental things.
(1:39:45) It's going to help lower the viscosity of blood. (1:39:48) It's going to soften arterioles, arteries, I mean. (1:39:51) And that's a very important factor.
(1:39:53) By the way, all of these things can be measured quite easily now through various mechanisms. (1:40:00) So again, very synergistic combination to take.
Julian Hayes II
(1:40:03) You know, I think about this, I don't, you know, this is sticking off the top of my head. (1:40:09) People who have had maybe a heart issue in the past, or maybe sometimes people have got this long COVID and they have these other symptoms as well. (1:40:18) And something to help build back the heart up, not saying not do this other stuff, but something like this is going to help as well.
Phil Micans
(1:40:25) Yeah. (1:40:26) One caveat, Julian, and that is, I am, of course, talking about people who are not taking any hardcore drugs.
Julian Hayes II
(1:40:33) Yes, yeah.
Phil Micans
(1:40:33) If there are people out there on, I don't know, what's that blood thinner called? (1:40:38) Dreadful stuff. (1:40:40) Oh, I should know this.
(1:40:41) I've learned my mind's not working at the moment, the American one terminology, the brand. (1:40:46) Anyway, I can't think of it at the moment, but there are certain very, very- Warfarin? (1:40:51) Warfarin, thank you.
Julian Hayes II
(1:40:52) Warfarin, yeah, my dad took that.
Phil Micans
(1:40:54) Did he, did he? (1:40:55) Yeah. (1:40:55) Otherwise known as rat poison.
(1:40:58) So, you know, because there's lots of ways of thinning blood. (1:41:00) There's some nice natural enzymes on the market like lumbrokinase or nattokinase or, you know, even eating pineapple to get the bromelain out of it, another enzyme that's very useful, a German product called Wobenzym, which is a combination of enzymes. (1:41:17) Anyway, we could go on.
(1:41:18) There are always choices. (1:41:19) There are always choices. (1:41:20) But if people are taking hardcore drugs, then I have to, of course, say, watch what you're doing because obviously, so to go back to our favorite, go back to the thyroid again, if the patient is taking thyroid hormones already and they start taking the peptide, they need to monitor themselves because almost certainly they will have to need to lower the dose of the hormone, may even stop it.
(1:41:48) Just depends how much they need to take. (1:41:51) So, but, you know, people who are taking drugs, okay, you need to take more caution. (1:41:58) But what we're talking about is health and fitness.
Julian Hayes II
(1:42:01) Yes.
Phil Micans
(1:42:02) People with concerns rather than actual problems.
Julian Hayes II
(1:42:05) And this is all for educational purposes and entertainment purposes. (1:42:09) And I forgot the other saying that I always say. (1:42:12) Right.
(1:42:12) But yeah, but no, that's true though, because these things are, people, a lot of times medications are gonna be in competing with a lot of, even some of the supplements and compounds out there now, if you start taking those, it's going to affect the dosage. (1:42:30) Yeah, absolutely. (1:42:31) That you're gonna have to take.
Phil Micans
(1:42:32) You know, I've seen people- Can I say, as a recovering pharmacologist, can I say that most drugs are treating the symptoms and they're not treating the problem? (1:42:43) So to come back to say warfarin, why is the blood thick? (1:42:48) Or why is the heart not beating correctly?
(1:42:52) As a, you know, why? (1:42:54) What you're doing, okay, you're thinning the blood. (1:42:56) I'm not saying that's not helpful and that's a step in the right direction, but it's not addressing the underlying cause.
(1:43:02) It's addressing the symptom. (1:43:04) It's like having pain. (1:43:06) Of course, you're going to take a painkiller.
(1:43:08) And don't get me wrong. (1:43:09) I'm not against drugs, but you know, that's necessary relief. (1:43:13) But the question remains, why have I got pain?
(1:43:17) Right? (1:43:18) And can we address that, you know? (1:43:20) So.
Julian Hayes II
(1:43:22) Yeah. (1:43:23) And I guess last one I'll touch on is, I think I saw one on the cartilage. (1:43:28) And so would you, I would think it may be athletes.
(1:43:32) Yes. (1:43:33) Yeah.
Phil Micans
(1:43:34) Very much. (1:43:35) No, the cartilage is another good one. (1:43:36) Another good seller.
(1:43:38) And I think over the years, I've discovered that there are a couple of things that not medical problems, but people jump to very quickly. (1:43:47) One is eyesight. (1:43:49) If one sees a deterioration in one's eyesight.
Julian Hayes II
(1:43:51) Oh, I forgot to mention that. (1:43:52) Yeah. (1:43:52) We'll go back to that.
Phil Micans
(1:43:53) We'll go back to that.
Julian Hayes II
(1:43:54) Okay.
Phil Micans
(1:43:54) And people tend to react quickly to that. (1:43:57) What I'm saying, right? (1:43:58) There's certain things people don't, you know, if you see your energy levels going down, it may be a long time before you actually address it.
(1:44:04) Okay. (1:44:05) And when you get really bad. (1:44:06) But joints is the other one, because as soon as you start moving your leg, your arm, your hip, wherever it is, and you're going out, just getting in and out of the car and out when you stand up and out, it's not long before you address that problem because it's with you all the time.
(1:44:23) So yes, the cartilage is another very interesting biomarker, not biomarker, forgive me, bioregulator. (1:44:34) Now I've got a bit of a story off on this and I could lead you down a rabbit hole, but I'll just say this as a problem. (1:44:42) Most people, and let's take the knee, nice, easy one.
(1:44:46) So most people, they're the two bones, of course, and then you've got cartilage around the bones, softer material, and then you've got a substance in the middle called synoval fluid. (1:44:57) We think of a shock absorber. (1:44:59) That's kind of like the oil in the middle.
(1:45:01) And then the cartilage is like the rubber on the shock absorber. (1:45:07) So if you think of it like, I always use car analogies. (1:45:09) I don't know why, I think most people get it.
(1:45:12) There's a number of things you can do. (1:45:13) Now, the problem might not be your cartilage. (1:45:17) Most people jump straight into my cartilage.
(1:45:20) Now I got this from a brilliant surgeon, Italian surgeon, who has done something amazing. (1:45:28) We'll come back to that if you want to, in this field. (1:45:32) And I asked him once, I said, is it bone-touching bone?
(1:45:36) He went, if that happened, he said, it's beyond pain. (1:45:41) He said, that would be excruciating. (1:45:43) That was the word he used, okay?
(1:45:45) So I went, oh, and of course, most people are not experiencing excruciating pain, right? (1:45:51) It's painful, but it's not excruciating. (1:45:53) So I said, so, okay.
(1:45:54) He said, what has happened in most of the people? (1:45:57) Has there been some cartilage loss? (1:45:59) Yes, quite possibly.
(1:46:02) Has there been loss of synoval fluid or reduced, in this case, reduced viscosity of synoval fluid? (1:46:10) Yes, because in this case, you want it to be more kind of gel-like, right? (1:46:15) Yes, he said, that could be true in these people.
(1:46:18) He said, but normally what they find is the cartilage has become calcified, over-calcified. (1:46:28) And what happens when the cartilage becomes over-calcified, it becomes kind of inflexible. (1:46:34) And the nerves that reside within the cartilage have stretched to an unnatural position.
(1:46:42) Ergo, when you move a little bit, they go, ow, they send the message. (1:46:47) Some of the most productive, fast acting, and I think this is where the bioregulator is playing its primary role, is in the decalcification and softening of the cartilage. (1:47:02) And what we see in as little, in some cases, as 10 days, in some cases, is, and what we believe is happening, is with the decalcification, the nerves are going back to their natural position.
(1:47:16) So a lot of patients after about two weeks go, I've got no more pain.
Julian Hayes II
(1:47:21) Wow.
Phil Micans
(1:47:22) It hasn't started regrowing cartilage, it's simply put the nerves back into their natural position.
Julian Hayes II
(1:47:32) So, okay, I'm gonna go to jump to a different area then. (1:47:35) So like in the lungs. (1:47:38) Yes.
(1:47:39) That's still regular upregulating the genes, right?
Phil Micans
(1:47:43) Yes. (1:47:44) Sorry, I'm just having to write a message to my daughter, but I am listening.
Julian Hayes II
(1:47:47) Yeah, and so, okay, so if we're in the lungs, and upregulating those genes is helping, going to help with lung functioning.
Phil Micans
(1:47:55) Yeah, what, I can tell you a specific story in this particular case. (1:48:01) So we had a Chinese, well, Malaysian gentleman, actually, by his extraction. (1:48:07) A very well-known accountant, at least here in the UK.
(1:48:12) And he loved vaping. (1:48:16) Okay? (1:48:17) And he vaped all the time.
(1:48:20) Not smoked, but vaped. (1:48:22) And I don't know if that was a specific problem, or the fact that he was buying, because he was going backwards and forwards to the Far East a lot, that he was buying these cheap Chinese vapes, apparently. (1:48:33) And of course, there's been lots of questions about the amounts of heavy metals in these things, et cetera, et cetera, et cetera.
(1:48:39) Why anyone wants to do it, I don't know. (1:48:41) I don't get it. (1:48:41) It doesn't interest me.
(1:48:43) I see these clouds of smoke, like they're a steam train coming out of these people. (1:48:47) But anyway, he did. (1:48:48) Well, very active man, was gonna be a pilot, had his eye on buying a jet aircraft.
(1:48:56) Life was good, everything going well. (1:48:59) And suddenly, within a few months, he deteriorated so fast, it was unbelievable. (1:49:05) And they took a look at him, and his lungs were just messed up, to the point where they were recommending at least one of the lungs to be replaced.
(1:49:17) Oh, Jesus. (1:49:18) So life-changing, completely life-changing. (1:49:22) Almost out of desperation, he decided, because he went through the orthodox approaches, and his life was, you know, he couldn't work, he couldn't get out of the house.
(1:49:35) I mean, it was really going badly for him. (1:49:37) So he actually started taking the lung peptide, in this particular case, to a day. (1:49:45) Within a month, he was coughing up, at first it seemed bad news.
(1:49:51) He was coughing up thick black mucus. (1:49:55) But it was actually doing something. (1:49:58) It was clearing his lung of the problem.
(1:50:01) And I'm not saying he's in the greatest of health today, but he has avoided having a transplant. (1:50:08) They actually now think that his lung is working to a reasonable capacity for him not to have a transplant. (1:50:16) Now, I can't put my hand on my heart and say, oh, that was definitely the bioregulator.
(1:50:21) It was absolutely given that within 10 days of him starting on that, that this process of coughing up this thick black mucus started. (1:50:30) And actually, that's what the bioregulator is. (1:50:33) It's actually taken from the mucus and the linings of the lungs.
(1:50:39) That's actually what it is. (1:50:43) So that's my direct experience with it, although I can't say too much more on that particular one. (1:50:49) I'd have to go back to you, Jake, for more information.
Julian Hayes II
(1:50:52) Yeah, we're all in a void. (1:50:53) And the last one here, just to kind of wrap this up, because I know we mentioned it a couple times, is the eyesight, and I saw that there's like eye drops.
Phil Micans
(1:51:00) Yeah, well, yes. (1:51:02) There is a oral retina peptide called Visoluten, and there is also an eye drop, although technically, it's called Can-C, the eye drop, and technically, it's not a bioregulator, but it is a short-chain peptide. (1:51:18) It's Carnosine, or N-Acetylcarnosine, to be precise, which is a dipeptide. (1:51:23) But it's not, I know we said at the beginning, what the bioregulator has to be is short-chain peptide. (1:51:30) And then I said to you, but not all short-chain peptides are bioregulators. (1:51:34) They have to show that they're gene switches.
(1:51:36) They have to show that they have this ability of both activating and silencing. (1:51:42) And I suppose I should say that, as the head man behind this is Professor Khavinson, that Professor Khavinson should bless it as a bioregulator, as the last, as the last factor. (1:51:56) But in this particular case, these eye drops, which really weirdly are also Russian design, although they come from a completely different institute in Moscow.
(1:52:07) The Helmholtz Science Institute. (1:52:09) They actually gave the world cataract surgery. (1:52:12) They were the first ones to do it and design it, et cetera.
(1:52:15) Anyway, but it's very effective for cataracts. (1:52:19) And it has to be used over five, six months, but it's been shown to reduce, remove, even dissolve cataracts. (1:52:26) So it has other effects, but the clinical trials have been focused on cataracts, specifically senile cataract.
(1:52:37) But is there anything else on the planet that has been proven? (1:52:41) 89% of the people who used it for five to six months had improvements. (1:52:46) And there are, I have eye photographs of cataract, no cataract in some people.
(1:52:51) I'm not saying every single person gets rid of them, but the fact is that you can improve the cataract, reduce the glycosylation within the cataract, which is the problem. (1:53:02) The word cataract is Greek. (1:53:04) It means waterfall.
(1:53:05) And I think it's because if you have one, it's a bit like trying to peer through a waterfall, right? (1:53:12) It's kind of blurry. (1:53:14) So that gets reduced.
(1:53:16) It's the crystallines within the lens. (1:53:18) So there's an anti-glycation effect. (1:53:21) That same mechanism may also be responsible for reducing intraocular pressure in the eye.
(1:53:29) In other words, it can help people with glaucoma. (1:53:33) And believe it or not, we actually also believe the same problem is the same problem for people with dry eyes because these cross-linked proteins, which is what glycation is, it's a reaction between oxygen and proteins and glucose. (1:53:52) Yes, it occurs within the lens of the eye, but it also occurs in the schlimm canal.
(1:53:57) This is the thing in the bottom of the valve in the bottom of the eye that things are moved in and out. (1:54:02) It kind of like getting a clogged drain. (1:54:06) And so because Can-C helps to reduce these, we believe that's how it is lowering intraocular pressure. (1:54:12) It's unclogging the drain, okay? (1:54:15) And in the lacrimal ducts, the things that put tears on our eyes, and you don't have to be crying to have tears on your eyes. (1:54:23) The fact that we blink without pain is because there's a fluid on our eye all the time, right?
(1:54:28) From the lacrimal ducts. (1:54:29) It's only when we get an excess of that that we see tears rolling down our cheeks. (1:54:34) And people with dry eyes, they have that problem.
(1:54:37) Well, we think the same thing happens. (1:54:39) We think that the lacrimal ducts get clogged. (1:54:42) We've actually had people, after using Can-C for some months, say, I don't have dry eyes anymore. (1:54:50) And we go, well, yeah, but there are lubricants in Can-C, so it alleviates straight away. (1:54:54) We know that. (1:54:55) No, I don't need to use Can-C anymore. (1:54:57) I haven't got dry eyes anymore. (1:54:59) So in other words, their natural eye fluid is back on the eye. (1:55:03) So that, I think, is fascinating, okay?
(1:55:06) So, and when it comes to the retinopeptide, we've got other evidences for macular degeneration, reversing, and in Russia itself, although I will caveat this with saying you have to use the injection to get the results, they have even reversed a condition known as retinitis pigmentosa. (1:55:25) As far as we know, there is no clinic in the world that can reverse this rather rare, thankfully, and probably genetically inherited problem than the one in St. Petersburg. (1:55:43) It's called the Tree of Life Clinic, and it's run by Professor Svetlana Trofimova. (1:55:49) And they are using the retinopeptides. (1:55:52) So that shows you the power of them, you know? (1:55:58) And in our little book, and by the way, there is another book I could mention, which is called Eyesight Saviours, written by Dr. Marios Kyriazis, Eyesight Saviours. (1:56:10) And there's chapters in there about different things that will help different eye problems. (1:56:15) And yes, Can-C's in there, melatonin's in there, and zinc's in there, and lots of good things are in there. (1:56:20) But there is a chapter in there about the retinopeptides, and that's good, because what you end up seeing is you see these photographs, computer scans of the backs of the eyes of people.
(1:56:31) And it's done in colors. (1:56:33) So black would mean no eyesight at all. (1:56:36) Red would mean poor eyesight.
(1:56:39) Yellow would mean okay-ish. (1:56:42) And green means normal, healthy eyesight. (1:56:45) And you see the before and afters, and everyone could work it out from that.
(1:56:49) And there are some extreme cases in there. (1:56:52) The most extreme one was an elderly lady who was 90, that's nine-oh, percent blind in that eye. (1:57:00) And after a year and a half's treatment, and that wasn't every day, by the way, it was nothing like that, she was 30% blind in that eye.
(1:57:09) Now, you might say, well, that's not a cure, is it? (1:57:12) That made such a difference in that lady. (1:57:15) So from being near blind to being able to see the grandchildren and move around the house, and any doctor out there will know to take someone from an extreme end to a much more normal end is remarkable.
(1:57:31) Because normally, across the board, everything works better if you treat early.
Julian Hayes II
(1:57:36) Yes. (1:57:38) Wow. (1:57:39) I think this is a great stopping point here.
(1:57:43) We could have did this probably two more hours. (1:57:45) There's so much more that we could have talked about. (1:57:48) We're going on two hours, and I don't think, this might be the longest conversation I've done on here.
(1:57:54) No, no, no, I appreciate it. (1:57:56) Thank you so much for taking your time to block out and just to really go in depth with this. (1:58:02) I think this is an awesome, awesome foundation.
(1:58:05) We laid out the foundation, we laid out what these are, and also the protocol to get started. (1:58:09) So this is like a definitive guide for people. (1:58:13) And so I'm gonna have this in written format as well.
Phil Micans
(1:58:16) I'm gonna take the time to- It's been my pleasure and I enjoy it. (1:58:19) And like I say, on a Friday afternoon, good time to catch me. (1:58:22) Yeah, awesome.
(1:58:23) And I know you're gonna put links in your video here where people can get more information and everything. (1:58:29) So yeah, more power to your elbow, as we say.
Julian Hayes II
(1:58:32) Well, I appreciate it, yes. (1:58:33) I will have all his information in the show notes as well. (1:58:36) And is there a preferred site?
(1:58:38) I know you have a different sites, but you think that Profound Health is the best one?
Phil Micans
(1:58:41) Well, no, I would say it's that. (1:58:43) Profound Health is a store.
Julian Hayes II
(1:58:45) Okay.
Phil Micans
(1:58:45) If you really want information, the two main sites we provide that is antiagingsystems.com.
Julian Hayes II
(1:58:51) Okay.
Phil Micans
(1:58:52) A warning for folks, there's a fantastic amount of information on that site about a lot of subjects, but you can search for what you want and hopefully you'll find it. (1:59:02) And then the other one is our magazine website, which is kind of more glossy and magaziney. (1:59:08) And that's agingmatters.com.
(1:59:11) So, and folks, although we charge if you want to buy a magazine, they can be downloaded free.
Julian Hayes II
(1:59:17) So awesome, awesome to hear. (1:59:19) And so I thank you for the book recommendations as well. (1:59:22) And all this, I have a lot to study.
(1:59:24) I'll put it that way. (1:59:25) I have a lot to study and everything.
Phil Micans
(1:59:28) Life is a learning curve. (1:59:29) We never stop, we never stop.
Julian Hayes II
(1:59:32) Very much so. (1:59:33) But listeners out there, stay awesome, be living lesson as always, go be the CEO of your health and your life. (1:59:38) Peace.
